Politicians, athletes, journalists, NGOs, companies... They all use
corporation-owned social networks to communicate with us. Citizens
shouldn't have to hand over their data to companies to read content
published by public entities. Public Feeds changes that by making posts
of popular accounts freely available.
Read more.
Advanced Research Projects Agency for Health
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the United States Department of Health and Human Services. Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity." More on Wikipedia
Official Twitter account of the Advanced Research Projects Agency for Health (ARPA-H).
Privacy Policy: https://t.co/Z855rcfwXT
Engagement ≠ endorsement
Why should advanced care be tied to a hospital building?
ARPA-H is breaking medicine out of the hospital.
PARADIGM’s MARCUS platform is bringing imaging, labs, dialysis, cancer care, OB/GYN services, and more into one mobile system built for rural communities.
Watch to learn how MARCUS is changing the future of rural care.
Across rural America, families often travel long distances to access essential healthcare services. @ARPA_H is investing in breakthrough technologies that bring advanced care closer to home.
This week, follow ARPA-H: Every Mile, Every American as the agency travels across rural communities to highlight the patients, clinicians, and innovations shaping the future of rural healthcare.
Why should advanced care be tied to a hospital building?
ARPA-H is breaking medicine out of the hospital.
PARADIGM’s MARCUS platform is bringing imaging, labs, dialysis, cancer care, OB/GYN services, and more into one mobile system built for rural communities.
Watch to learn how MARCUS is changing the future of rural care.
Yesterday, @SecKennedy made announcements on new HHS and @ARPA_H funding that will advance the development of mental health treatments for veterans and civilians including an almost $5 million in ibogaine as a potential PTSD treatment, and $20 million to support research on rapid-acting psychotropics interventional drugs.
Joining Secretary Kennedy for the press conference were @DrOzCMS, @FDA_KyleD, Chief Medical Officer for ARPA-H Dr. Rafid Fadul, Acting Director of the National Institute of Mental Health Dr. Andrea Beckel-Mitchener, and @DeptVetAffairs Senior Advisor Andrew Gradison.
ARPA-H reposted
University of Pittsburgh School of Medicine@pitt_medicine
#pittmed researchers and @UPMCHillmanCC received a 2-year, $4.385M @ARPA_H award to explore whether quantum particles generated during radiation therapy can reveal critical real-time information about tumors that conventional imaging may miss.
Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options.
HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD, alongside a new $20M funding opportunity to study rapid-acting treatments like ketamine, esketamine, and psilocybin.
.@SecKennedy makes MAJOR ANNOUNCEMENT on investments to advance research into ibogaine as a potential treatment for PTSD!
“@HHSGov is committing up to $4.9 million through @ARPA_H to advance ibogaine treatments for PTSD. These awards will support the scientific, regulatory, and manufacturing work necessary to prepare for future U.S. clinical trials.”
HAPPENING NOW: @SecKennedy announces new @HHSGov and @ARPA_H actions to advance innovative mental health treatments for veterans and Americans nationwide.
.@SecKennedy on Beond’s role in accelerating ibogaine research:
“Beond, a Texas-based company that operates a hospital in Mexico, has treated more than 3,000 patients and administered 6,000 doses of ibogaine. The company uses evidence-driven, physician-led, hospital-grade treatment protocols, and they’ve agreed to turn that research over to us, specifically to @ARPA_H. That is going to allow us to dramatically accelerate the clinical trial process.”
HAPPENING NOW: @SecKennedy announces new @HHSGov and @ARPA_H actions to advance innovative mental health treatments for veterans and Americans nationwide.
HAPPENING NOW: @SecKennedy announces new @HHSGov and @ARPA_H actions to advance innovative mental health treatments for veterans and Americans nationwide.
This Veterans Day, we honor and thank all who have served our country.
For many veterans, PTSD and other behavioral health conditions still mean trial-and-error care. ARPA-H is building first-of-their-kind tools to change that.
Through Delphi, ARPA-H is investing up to $38M in PYTHIA, an MIT-led wearable that uses body heat and on-chip SI to track heart failure and sepsis biomarkers.
On ATDev Podcast, PM Mansoor Khan breaks down how ARPA-H backs high-risk health ideas and how RAMMP is using robotics and AI to give people with disabilities more independence.
#scientificsessions26: @BrandonFornwalt will join fellow @ARPA_H ADVOCATE awardees on stage to discuss how they are building AI-clinician extenders designed to expand access to cardiology expertise for heart failure patients.
The vision from the @ARPA_H visionary “BoSS” Dr. @Gloria Elliott kicks off a future where living cell therapies can move beyond ultra-cold storage to scalable, accessible medicines.
🔬 Our CEO @nabihasaklayen will lead "How To Be A Successful ARPA-H Performer" at @ARPA_H's BoSS Kickoff Meeting on Nov. 4. Nabiha will draw from her experience leading @CellinoBio and navigating an ambitious @ARPA_H-funded research initiative.
Day 2 of the 2026 Louis J. Fox Center for Vision Restoration VISION Conference is underway at the UPMC Vision Institute! 👁️ Today kicks off two days of presentations from researchers working on the ARPA-H Transplantation of Human Eye Allografts (THEA) program, led by ARPA-H Program Manager Calvin Roberts, M.D. The project is funded by the Advanced Research Projects Agency for Health and awarded to Stanford and its subcontractors. @ARPA_H
Around 49 speakers from every team are sharing progress on surgical approaches, donor selection, preservation, axon regeneration, immune responses, and nerve wrap therapeutics.
It's an exciting time for vision restoration research, and we're proud to host this conversation in Pittsburgh.
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Women live longer than men on average, but those additional years are not always spent in good health. Closing that gap requires research that better accounts for women's biology and addresses the health challenges they face throughout life.
The Women's Health Executive Order calls for more research into conditions ranging from cardiovascular disease and Alzheimer's to osteoporosis, menopause, and aging. It directs the NIH to establish a dedicated Women's Health Division within 90 days and creates a White House Women's Health Task Force to coordinate efforts across federal agencies, including @NIH, @FDA, @CMSGov, and @ARPA_H.
At A4LI, we believe everyone should have the opportunity to live a longer, healthier life. Recognizing aging as a women's health priority is an important part of that goal. Continued investment in research and innovation can help ensure that longer lives also mean more years lived in good health.
Medicine spent generations learning from a system that did not fully account for women.
The Women’s Health Executive Order opens the door to a different kind of progress, one that treats women’s biology as a priority for discovery, investment, and action.
At ARPA-H, we get to help push the science that can finally answer questions medicine has left unresolved.
Women’s health has been sidelined for generations. The mandate to change that is here.
The Women’s Health Executive Order from @FLOTOS and @POTUS directs federal agencies to prioritize fertility, menopause, cardiovascular, bone, metabolic, and brain health.
At ARPA-H, we are built to take on the hardest problems where medicine has not delivered.
Now we are making big bets that can produce entirely new breakthroughs for women.
Before disease takes hold, there may be a window to stop it.
ARPA-H’s BIOGAMI program is targeting the earliest stages of protein misfolding, and patient advocates are helping shape how that work moves forward.
Earlier intervention starts with listening.
ARPA-H reposted
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Osteoarthritis affects tens of millions of Americans, and advanced cases can leave patients with few options beyond joint replacement. Current treatments can help manage pain and improve function, but regenerating lost cartilage and bone remains a major challenge.
@ARPA_H's Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program is working to change that. Research teams at Duke University, the University of Colorado Boulder, Columbia University, and other institutions are developing experimental approaches ranging from targeted drug delivery to 3D-printed, living joint scaffolds. In animal studies, some approaches have shown promising signs of cartilage regeneration. The goal is to move these innovations toward human trials while developing treatments that could cost substantially less than current standards of care.
At A4LI, we're encouraged to see ARPA-H invest in research that could change how we treat age-related conditions. Maintaining joint health is essential to mobility and independence, and regenerative approaches could one day offer patients options beyond managing symptoms or replacing damaged joints. We'll be following NITRO as these experimental treatments advance toward clinical test.
.@FLOTUS reveals the @FirstLadyOffice’s 5 pillars for women’s health innovation:
1️⃣ Find cures for diseases affecting women in a unique way 2️⃣ Use superintelligence (SI) to enhance our understanding of female biology and speed up medical discoveries 3️⃣ Accelerate the process of guiding promising therapies from laboratories to female patients while maintaining strict safety standards 4️⃣ Ensure that medical breakthroughs are accessible and affordable to women regardless of their financial circumstances 5️⃣ Replace generations of silence with open conversation, education, and compassion
Supported by @ARPA_H, the @HopkinsMedicine#detr team, led by @XiaoboMao, is building #ai models that read a protein’s shape, not just its sequence, to support earlier disease detection and to identify therapeutic targets for conditions caused by protein misfolding.
America should lead the world in turning medical breakthroughs into treatments for patients.
HHS is cutting the delays, duplication, and unnecessary costs that hold clinical trials back. Through @ARPA_H, we are building a modern clinical trial system that generates rigorous evidence faster, reduces the burden on patients, and moves effective treatments from discovery to patients sooner.
Medical breakthroughs shouldn't take decades to reach the patients who need them.
Under @POTUS and @SecKennedy, HHS is modernizing clinical trials to cut delays, reduce costs, and accelerate medical innovation.
Through @ARPA_H's new SURPASS program and three complementary initiatives, we're harnessing AI, advanced technology, and real-time data to make clinical trials faster, smarter, and less burdensome for patients.
America should lead the world in medical innovation, and we're working to make sure promising treatments reach patients sooner.
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Diseases like Alzheimer's, Parkinson's, and ALS can develop over many years, with protein misfolding and clumping contributing to damage in the brain and nervous system. By the time symptoms appear, significant damage may already have occurred. Understanding how these changes begin could open new opportunities to detect and treat disease earlier.
@ARPA_H's new BIOGAMI program is tackling this challenge, investing up to $152 million over four years to understand how proteins become dysfunctional and develop ways to intervene. Six research teams, including those at the Buck Institute for Research on Aging, Johns Hopkins, MIT, and UC Berkeley, will combine protein science and computational tools to develop new approaches to early detection and treatment. While the initial focus is neurodegenerative disease, the findings could eventually have applications in cancer, diabetes, and other conditions.
At A4LI, we're encouraged to see ARPA-H invest in understanding the underlying biology of disease. The earlier we can identify and address the processes that contribute to age-related conditions, the more opportunities researchers may have to change how these diseases are treated. We'll continue following BIOGAMI's progress and highlighting the work underway at ARPA-H to advance biomedical innovation.
The next breakthrough in health shouldn't take decades.
ARPA-H is at #hlth2026 looking for the top cutting-edge ideas in AI, care delivery, and drug development & delivery. We take on high-risk challenges and turn them into real capabilities that reach patients fast.
We are proud to announce our expected participation in SEEDS, an Advanced Research Projects Agency for Health (@ARPA_H)-funded research consortium co-led by the @BuckInstitute and @Georgetown, to measure how disease-causing proteins misfold before irreversible damage occurs in Alzheimer's disease and cancer.
Many diseases begin with protein dysregulation, misfolding, and aggregation. Today, most treatments arrive only after irreversible damage has occurred. SEEDS aims to predict harmful changes in disease-causing proteins before that point and to use those predictions to develop new ways of detecting, slowing, and treating neurodegenerative diseases and cancer.
The four-year consortium has been awarded up to $51.7 million through ARPA-H's BIOGAMI program. Upon completion of contracting, Nautilus would be expected to receive up to $6 million over the course of the program to deploy the Voyager™ Platform to quantify proteoforms of tau, implicated in Alzheimer's disease, and EWS::FLI1, implicated in the pediatric cancer Ewing sarcoma. The work would be anticipated to then extend to a larger set of intrinsically disordered proteins. The resulting data would be expected to be used to train AI models to predict how proteoforms push a protein toward aggregation.
"We believe that the highly differentiated data from the Nautilus Voyager Platform has the potential to unlock a new generation of proteoform-enabled diagnostics and therapeutics." – Parag Mallick, Ph.D., Co-founder and Chief Scientist, Nautilus.
Excited to co-lead SEEDS with @Georgetown, supported by @ARPA_H! This ambitious collaboration aims to predict harmful protein changes linked to disease. More Monday on the science, researchers and partners! #buckinstitute#seeds#livebetterlonger
Investigator Randal Halfmann, Ph.D. (@HalfmannLab), will receive ~$4.1M from @ARPA_H to help find out, as part of a $28.6M national effort led by @UCBerkeley's Innovative Genomics Institute.
ARPA-H’s CIRCLE program is using AI-powered digital twins to model a patient’s immune response, test treatment strategies virtually, and help ICU teams act earlier with more personalized care.
China has gained swift ground on clinical trials by making them faster and cheaper.
Thanks to @SecKennedy, @ARPA_H is meeting the challenge with the SURPASS model for clinical trial competitiveness: ⚡ Lower development time and cost 📊 Real-time data 🤖 Automation 🔬 Phaseless trials
Autism changes across a lifetime. Care has to keep up.
In a new @statnews interview, SPECTRA PM Russell Shilling shares how ARPA-H’s SPECTRA program is breaking down research silos to pursue more precise, individualized support.
As the father of two autistic children, he knows the stakes firsthand.
ICYMI: @SecKennedy, @HHSGov, and @ARPA_H announced SURPASS—a new program designed to bring faster, cheaper clinical trials to get Americans access to live-saving treatments and drugs.
AI is reshaping how biomedical research gets done.
Join IGoR Program Manager Yoram Vodovotz, Ph.D., for a GovExec webinar on how AI can help scientists turn complex data into faster, smarter research decisions.
Your body is constantly changing. Most wearables barely scratch the surface.
Recently, ARPA-H announced the Delphi team developing a new class of biosensors designed to continuously track a much wider range of biological signals.
From single metrics to a real-time window into the body.
ARPA-H is heading to #hlth2026 in Las Vegas Nov 15-18. If you're working on something that could change how care is delivered — from AI diagnostics to new models of access — we want to hear about it.
She once delivered rural pediatric care from a converted van.
Years later, Violet Chadwick stepped inside MARCUS.
ARPA-H’s PARADIGM program built this mobile platform to bring advanced care into rural communities—modular spaces and specialist access traditional mobile clinics never had.
The compassion was always there. Now the tools match it.
We’re proud to announce that Verily Health has been selected by @ARPA_H to build the shared data platform for CIRCLE — giving ICU teams real-time visibility into a patient's immune system before organ damage occurs.
.@ARPA_H Director Alicia Jackson: “Without reforming and advancing and modernizing and changing the way we do clinical trials, nothing else will matter…Those drugs won’t be developed or they will be developed overseas and that means American patients won’t get access to them.”
Today in Austin, Texas, @SecKennedy joined @ARPA_H to unveil bold new initiatives aimed at transforming how clinical trials are conducted across the United States and retain biomedical research.
“It’s not just economic benefits that we’re losing; it’s the control of our healthcare, of our health. Our international leadership in biomedical research…We cannot afford to lose it.”
.@ARPA_H Director Alicia Jackson: “There is no reason for us not to be in the leader today [in clinical trials]. And I think this is our first opportunity in decades when you have such alignment with the White House, across @HHSGov. You have incredible support from @SecKennedy.”
Today in Austin, Texas, @SecKennedy joined @ARPA_H to unveil bold new initiatives aimed at transforming how clinical trials are conducted across the United States and retain biomedical research.
“It’s not just economic benefits that we’re losing; it’s the control of our healthcare, of our health. Our international leadership in biomedical research…We cannot afford to lose it.”
.@ARPA_H Director Alicia Jackson: “We’re announcing four major efforts today — probably the largest suite of investments that we’ve made in a singular area…We have so many people in desperate need of [clinical trial] treatments and therapies who can’t get access to them.”
Today in Austin, Texas, @SecKennedy joined @ARPA_H to unveil bold new initiatives aimed at transforming how clinical trials are conducted across the United States and retain biomedical research.
“It’s not just economic benefits that we’re losing; it’s the control of our healthcare, of our health. Our international leadership in biomedical research…We cannot afford to lose it.”
Today in Austin, Texas, @SecKennedy joined @ARPA_H to unveil bold new initiatives aimed at transforming how clinical trials are conducted across the United States and retain biomedical research.
“It’s not just economic benefits that we’re losing; it’s the control of our healthcare, of our health. Our international leadership in biomedical research…We cannot afford to lose it.”
.@SecKennedy on how the @ARPA_H projects announced today will keep the United States competitive for clinical research:
✅ New technology to be more predictive and careful in less time ✅ Elimination of delays and duplications which do not improve safety or science ✅ Reuseable infrastructure that allows more American sites to conduct trials outside of major medical centers
Today in Austin, Texas, @SecKennedy joined @ARPA_H to unveil bold new initiatives aimed at transforming how clinical trials are conducted across the United States and retain biomedical research.
“It’s not just economic benefits that we’re losing; it’s the control of our healthcare, of our health. Our international leadership in biomedical research…We cannot afford to lose it.”
MiNK’s clinical-stage agenT-797 iNKT platform has been selected as a therapeutic cell system for @ARPA_H ’s four-year BoSS program, backed by up to $87M to advance living medicines toward room-temperature storage. MiNK release: investor.minktherapeutics.com/press-releases ARPA-H announcement:
UVM has received its largest research award ever: Up to $38M from @ARPA_H for @UVMLarnerMed's Dr. An to develop AI-powered “digital twins” to help clinicians personalize and improve treatment for critically ill patients and reduce ICU stays. More ➡️ go.uvm.edu/twin
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Many cell-based therapies, including treatments for cancer and autoimmune disease, currently rely on storage at temperatures as low as -196°C. Maintaining that ultra-cold supply chain adds significant costs and can make these therapies harder to deliver where they are needed most.
@ARPA_H’s new BioStabilization Systems (BoSS) program is taking on that challenge, investing up to $87 million to develop technologies that could keep life-saving cell therapies stable at room temperature.
A 200-degree leap could mean more than eliminating freezers. It could help lower costs, simplify distribution, and make advanced therapies more accessible to patients and providers, including at community hospitals.
At A4LI, we’re excited to see ARPA-H tackle the infrastructure challenges that can stand between scientific breakthroughs and the patients who need them. Innovations that make advanced therapies easier to manufacture, transport, store, and administer will be an important part of building a health system capable of delivering the next generation of medicine.
As A4LI continues to advocate for policies that accelerate longevity and biomedical innovation, we look forward to highlighting more of the work underway at ARPA-H and across the biomedical research ecosystem.
A national collaboration led by Yale’s Andre Levchenko aims to provide intensive care teams with real-time insight into patients' immune responses before life-threatening complications occur:
A new federal program—ADVOCATE—will provide $62.7 million over 4 years to develop agentic artificial intelligence to transform cardiovascular care. Haider Warraich tells TCTMD’s Todd Neale where that work might lead. Read the full story linked here: www.tctmd.com/news/qa-haider-warraich-quest-agentic-ai-to…
#ai is rapidly entering health care, but adding more technology does not necessarily improve care and may add to alarm fatigue in already crowded clinical environments.
🎙️ In this episode of JAMA+ AI Conversations, @JAMA_current and @JAMAplusAI Associate Editor Yulin Hswen, ScD, MPH, spoke with Bon Ku, MD, MPP, program manager at @ARPA_H about how simulation-based testing may help assess artificial intelligence systems before they are used in real-world care.
🎙️ In this episode of JAMA+ AI Conversations, Yulin Hswen, ScD, MPH, spoke with Bon Ku, MD, MPP, program manager at @ARPA_H about how simulation-based testing may help assess artificial intelligence systems before they are used in real-world care.
Some of medicine’s most advanced therapies can be lost to an unplanned temperature change 🧊
ARPA-H just awarded three BoSS teams to take on the “200-degree leap” developing technology to store critical cell and gene therapies at room temperature – going from about -196°C to 21°C.
That leap could move fragile therapies out of cryogenic storage and into more hospitals.
The Chief Medical Officer at @ARPA_H, Dr. Rafid Fadul, talks about how ARPA-H, a government entity that has the objective of moving at market speed. This is incredibly important as their research scales quickly and helps to drive innovation.
4.6M Americans enter the ICU each year. And many face lasting complications for months or years.
The problem: patients' immune systems can swing from overactive to underactive faster than a lab test can process, leaving care teams reacting only after damage is done.
ARPA-H's CIRCLE program is building AI digital twins for real-time immune monitoring and control during critical illness.
.@ARPA_H is taking on one of autism care’s biggest challenges: one-size-fits-all thinking.
SPECTRA will bring cutting-edge science, AI, and real-world data together to pursue earlier diagnosis, precision care, and better outcomes across the lifespan.
.@SecKennedy shares new and recent @HHSGov actions to address autism:
▶️ @NIH launched the Autism Data Science Initiative ▶️ @ARPA_H launched SPECTRA — a major program that will integrate genetic, environmental, metabolic, immune, microbiome, and other biological data to advance autism research ▶️ The Interagency Autism Coordinating Committee is calling to nearly double federal funding for research
Autism doesn’t follow one pattern. Care can’t follow one playbook.
ARPA-H just launched SPECTRA to bring precision to autism diagnosis and care.
SPECTRA will turn biology, data, and real-world signals into earlier diagnosis and more tailored support — while building tools that support quality of like beyond the clinic.
We’re recruiting teams across genetics, AI, neuroscience, diagnostics, therapeutics, and assistive tech.
Imagine a hacker faking your fertility data—and you’d never know.
ARPA-H’s UPGRADE is catching the weak spots before hackers do.
@Northeastern researchers, backed by ARPA-H, found 20 holes in an at-home fertility device—enough to fake hormone numbers, steal health data, and impersonate the gadget itself.
The issues were disclosed responsibly and patches are already rolling out.
American patients shouldn't have to travel abroad to access treatments discovered here. American innovators shouldn't have to go elsewhere to test them. FDA's Expedited IND Pilot is part of the Trump Administration’s broader effort to make the U.S. the fastest, safest path from scientific discovery to clinical trial. www.fda.gov/news-events/fda-voices/america-first-approach…
The DCRI will lead the SYMPHONY Consortium, a national network testing AI agents for heart failure care across diverse health systems and rural sites. The goal: determine whether these tools are safe, effective, equitable, and scalable. duke.is/m/rw9v @american_heart
They mutate, adapt, and outsmart the drugs that once beat them back.
ARPA-H’s ADAPT builds cancer care that evolves with the tumor—using new biomarkers and predictive tools so clinicians can adjust treatment in real time.
Enrollment is now open for metastatic breast, lung, and colon cancer.
Ask your oncologist and search clinicaltrials.gov to see if ADAPT is right for you.
The best defense against a moving target is a treatment that moves too.
The American Heart Association is proud to be part of this important work advancing responsible AI in cardiovascular care. We’re helping assess these emerging AI technologies in real-world settings, including rural and under-resourced communities, while contributing our expertise, data resources and national network to the effort. Together we can change the future of health for everyone, everywhere.
Wheat germ cell-free systems have always used leftover germ from flour milling. Tritica Biosciences in Wamego, KS, starts from intact embryos, from cultivars chosen for protein yield.
Over 384 production runs. 107.5 L of extract. 5.76 metric tons of Kansas wheat.
A University of Minnesota Medical School research team has been awarded up to $6 million from @ARPA_H to develop new treatments for suicidality and severe mental illness.
Galois is excited to announce the kickoff of HealthyDocs, funded by @ARPA_H.
The growth of the fragmented healthcare data ecosystem has significantly outpaced our ability to secure it. Healthydocs offers a secure, scalable solution.
Seven companies. Five states. One question: can a grain of wheat make medicine?
@ARPA_H selected @Ginkgo and the WHEAT team, under a $29M program, to make medicine closer to the people who need it. Over the next week, follow along as we spotlight the partners doing the work with us:
We're excited to announce that Ginkgo has been awarded a subcontract for up to $17.5M under the Advanced Research Projects Agency for Health’s (ARPA-H) Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. We're looking forward to working alongside Waterfall Scientific on ESCALATOR (Engineering a Small-scale, Continuous-flow manufacturing Apparatus to Launch A Transformational Overhaul for RNA medicines), a multi-organization effort to compress end-to-end RNA drug manufacturing onto a benchtop footprint.
The Emerging Health Innovators Initiative pairs early-career talent with ARPA-H Program Manager mentors and gives them the tools to take on health’s hardest problems.
We are solving today’s challenges and training tomorrow’s leaders.
ARPA-H is seeking sensing, ML, pharma chemistry, and hardware teams for FASTPASS, our push to screen drug shipments in minutes before they reach patients.
Millions get hit by recalls every year after unsafe meds already hit shelves.
Help build the next generation of drug safety. Attend the Sept. 10th Proposers’ Day event. Registration closes September 4 at 12 PM ET.
Longevity treatments cannot reach patients if we cannot prove they are working.
ARPA-H’s PROSPR program is tackling that bottleneck.
A new @nytimes feature explores how PROSPR is using intrinsic capacity — including strength, mobility, cognition, and vitality — to measure healthy aging on a timeline that works for medicine.
Through PROSPR, ARPA-H is creating a path for treatments that extend healthy years to reach all Americans.
Diagnosis takes six years on average—for some, it can take decades.
Only 5% have an approved treatment.
ARPA-H is changing the pace with RAPID—using AI, data, and scalable systems to diagnose rare diseases faster and support the development of new treatments.
One of the most common Qs: "You can't run a trial for aging. What do?"
"Intrinsic Capacity" is the most important term to know for people who care about how we will be able to test new medicines for their ability to keep people living longer and healthier. This is a great intro by @SmithDanaG - featuring @BrackLab who is spearheading the first effort to test new drug candidates in IC as part of @ARPA_H PROSPR
ARPA-H is putting that capability directly into clinicians' hands.
SRI International is developing AI-guided tools for blood draws, splinting, intubation, and more — bringing advanced clinical care to communities that need it most.
That's PARADIGM — more tools, more places, more patients.
Two research teams of Hopkins engineers will collaborate with @Philips North America and @Kitware on newly-funded @ARPA_H projects to create, test and validate #autonomousrobot solutions for #stroke.
The Adamson @bsadamson Lab is collaborating on a new five-year initiative funded by the Advanced Research Projects Agency for Health @ARPA_H supporting work to develop affordable gene-editing therapies for children with inborn errors of immunity (IEIs). molbio.princeton.edu/news/2026/adamson-lab-innovative-col…
In @NatureMedicine, ARPA-H PMs David Gunning, @BonKu, and Haider Warraich argue AI should be evaluated on real clinical tasks and patient outcomes -- not abstract benchmarks.
Better evaluation is how safer AI reaches patients.
Our new summary report synthesizes insights from regulators, geroscience researchers, clinicians, trialists, funders, and product sponsors on bridging the gap between biological aging research and approved therapeutics.
USC researchers John Oghalai and Brian Applegate’s startup, AO Technologies, has received a Small Business Innovation Research award of up to $3.7 million from the Advanced Research Projects Agency for Health. With this funding, Oghalai and Applegate will advance clinical imaging of the inner ear, helping improve patients’ quality of life. Read here: uscne.ws/inner-ear
Boston Children's Hospital, in partnership with the @broadinstitute and @JacksonLab, is launching the Center for Therapeutic Genetics to make #raredisease gene therapies faster to develop and deliver to patients, while Mass General's work is focused on rare genetic vasculopathies.
🪙 A NEW funding opportunity on pharmaceutical safety 🧗🏽 Deep dive on what qualifies as “ARPA-Hard” ♿ Updates on RAMMP, ARPA-H's high-tech mobility device
Vitals is your look inside the programs shaping the future of health.
🎥 A panel on ARPA-H's longevity-focused projects featuring Andrew Brack, Jean Hebert, and Gloria Elliott, exploring how innovative research efforts could help accelerate progress toward healthier, longer lives.
@ARPA_H awarded GEMMABio up to $4M for RAPID, a THRIVE project with @ProfluentBio. The teams will test AI-designed, LNP-delivered base editors for founder mutations causing HoFH and MSUD.
Behind every rare disease is a child, a family, and a future worth fighting for. @ARPA_H's $160 million investment in custom gene editing is more than a figure — it's a commitment that rare disease patients will not be left behind.
ARPA-H is proud to be part of the @HHS + @DepVetAffairs effort to bring safe and effective mental and behavioral health treatments to those who need them most.
Yesterday, @SecKennedy joined @SecVetAffairs Doug Collins to sign a Memorandum of Understanding between HHS and the Department of Veterans Affairs to advance research into psychedelic therapies and other innovative treatments for veterans.
This partnership will help expand clinical research, prepare healthcare providers, and ensure veterans can access safe, FDA-approved treatments as they become available.
America's veterans deserve access to every safe and effective treatment modern medicine can offer.
I joined @SecVetAffairs Doug Collins to launch a landmark partnership between @HHSgov and @DepVetAffairs to accelerate research into psychedelic therapies for veterans. We will follow the science, build the evidence, and move promising treatments forward for veterans living with PTSD, depression, and addiction. They served our country. Now it's our duty to deliver the care they deserve.
Lymphatic dysfunction is a hidden driver of chronic disease. Patients still spend years searching for answers.
ARPA-H's LIGHT and GLIDE programs are changing that: building new tools to detect, treat, and prevent lymphatic dysfunction before it drives something worse.
The FDA's Home as a Health Care Hub Initiative launches the "READI-Home: Reducing Readmissions through Device Innovation for the Home” innovation challenge to accelerate patient access to at-home medical technologies aimed at reducing hospital readmission. www.fda.gov/medical-devices/home-health-care-hub/fda-read…
Proud to be part of @ARPA_H's GLIDE program & look forward to this important conversation on lymphatic health. Seaport & @MonashUni received up to $15M to advance Seaport's GlyphCele, a Glyphed oral prodrug designed to restore gut lymphatic function & improve patient outcomes
Lymphatic dysfunction is a hidden driver of chronic disease. Patients still spend years searching for answers.
ARPA-H's LIGHT and GLIDE programs are changing that: building new tools to detect, treat, and prevent lymphatic dysfunction before it drives something worse.
Proud to contribute to Broad Institute-led PERC Gene Editing Platform, selected to receive up to $34.5M from @ARPA_H THRIVE program. Together we're working to advance gene-editing approaches for rare pediatric epilepsies, including Dravet syndrome & AHC. www.broadinstitute.org/news/broad-led-consortium-receives…
We're proud to announce that we've been awarded a five-year, up to $38.9 million award from @ARPA_H THRIVE program to support the advancement of personalized gene therapies focused on four groups of rare, liver-related genetic disorders.
We're thrilled to announce that a Broad-led consortium of 12 organizations has been selected to receive funding from @ARPA_H under its THRIVE program to launch the Pediatric Epilepsies and Rare CNS (PERC) Gene Editing Platform. broad.io/ARPA-H (1/5)
Lymphatic dysfunction is a hidden driver of chronic disease. Patients still spend years searching for answers.
ARPA-H's LIGHT and GLIDE programs are changing that: building new tools to detect, treat, and prevent lymphatic dysfunction before it drives something worse.
Technology for monitoring fetal health during labor hasn't changed in 50 years. New CMU-led research could change that. 🩺
CMU is leading a multi-university team that has secured up to $39.3 million from @ARPA_H to develop a wearable system to better identify fetal distress.
In the world of eye transplants, one nerve has stood between blindness and sight – until now.
ARPA-H’s Transplantation of Human Eye Allografts (THEA) program has delivered a major breakthrough in optic nerve regeneration, bringing restored vision closer to reality.
Take a look at the work @harvardmed and @MassEyeAndEar are doing to push this groundbreaking work forward.
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Straight from the agency leading some of the boldest health innovation in the country. We're honored to welcome @ARPA_H Director Alicia Jackson for a conversation on what's next for high-risk, high-reward longevity research.
The Alliance for Longevity Initiatives (A4LI)@theA4LI
What happens when DARPA-style ambition meets human health? Our panel is exploring the boldest longevity projects coming out of @ARPA_H — and what they could mean for the future of aging research.
Moderator: @soniaarrison Panelists: Andrew Brack, Jean Hebert, Gloria Elliott
ARPA-H reposted
The Alliance for Longevity Initiatives (A4LI)@theA4LI
How do we unlock federal funding for longevity science? Our workshop is getting into the mechanics — and how advocates, researchers, and policymakers can work together to make it happen. Featuring many speakers from @ARPA_H!
When critical care is hours away, rural Americans get sicker and die younger.
ARPA-H is closing that divide. In just 18 months, PARADIGM performers @missionmobileNC and @Plan_Sys built mobile hospitals and cleared independent testing.
PARADIGM is putting advanced care on wheels and bringing it directly to rural communities.
90% of your life is spent indoors. Americans have spent decades forced to accept that indoor air quality is unmeasurable and uncontrollable. The consequence? Kids have asthma attacks. Patients get infections. Employees rack up sick days.
@NYT went inside ARPA-H’s BREATHE program and the race to deploy the technology to make clean indoor air a public health standard.
Day two at #bio2026 focuses on securing America’s innovation leadership.
At 4:15 PM PT in Hall 28ABCDE, ARPA-H Chief Medical Officer @DrRafidFadul joins the Super Session “Securing U.S. Innovation Leadership on Behalf of Patients.”
Visit Booth 6157 to meet the ARPA-H team and share the health challenges you believe demand a new approach.
Osteoarthritis is the 3rd most common disability in the U.S., affecting 32M+, and treatment usually means risky, invasive surgery.
🧬ARPA-H's NITRO program — featured in the @WSJ — Aims to unlock joint regeneration and render these procedures obsolete. That’s a life-changer for millions.
100+ rural hospitals closed in 10 years. CT scanners: still fixed to hospital walls.
ARPA-H's PARADIGM is changing both — mobile, hospital-level care built to reach patients wherever they are. We saw it in action at @MassGenBrigham. @BonKu
The future of health is on display at #bio2026 Meet our Program Managers, experience ARPA-H Alive, and see —not just hear— how we're shaping the future of health.
150 million Americans struggle with poor sleep. Current insomnia treatments fail more than 70% of patients.
ARPA-H launched REST to move sleep medicine beyond tracking and into treatment.
We are looking for leading teams across sleep, neuroscience, biosensing, AI, engineering, and neuromodulation ready to take on one of the biggest drivers of health.
More than 70 million Americans live with hearing loss.
ARPA-H’s HEARING program is taking on hearing loss as a neurological challenge, advancing a minimally invasive, brain-driven system that works with the auditory cortex.
We are calling on teams across neuroscience, otology, engineering, AI, neuromodulation, audiology, and regulatory science.
How do we tell whether a drug helps people function better and stay independent longer as they age? We think Intrinsic Capacity is a promising place to start. We recently shared our @ARPA_H-led consensus framework at the @reaganudall meeting with @US_FDA regulators. We are calling on researchers and trialists to build evidence for the use of IC across trials.
At last week’s Healthy Buildings Demonstration Session, ARPA-H BREATHE and PRO-MICROBE performers showcased technologies that will usher in a new era in public health.
A future where buildings can detect airborne threats earlier.
Where indoor spaces can proactively respond before risks spread.
ARPA-H is working to make cleaner, safer indoor air a standard Americans can expect.
Mayo Clinic has been named a sub-awardee in the @ARPA_H PARADIGM program to expand access to hospital-level care in rural and remote communities.
By developing artificial intelligence-guided tools, the team aims to help clinicians safely perform procedures and bring high-quality care closer to patients nationwide. #ai#ruralhealth
The Alliance for Longevity Initiatives (A4LI)@theA4LI
Our H-SPAN Summit DC is just around the corner. This year, we’re building on last year’s conversation about cross-agency alignment in funding and regulatory frameworks for longevity.
We are thrilled to close Day 2 of the Summit with a landmark session: “Building the Framework: Policy Levers for Longevity Innovation.” For the first time, senior administration leaders and Members of Congress will join in a singular forum to discuss current federal initiatives and legislative levers that set out to make healthy longevity a national priority and achieve a true "longevity dividend."
Featured speakers for this policy-focused second day include: •Dr. Mehmet Oz (Tentative), Administrator of the Centers for Medicare & Medicaid Services (CMS) •Lowell M. Zeta, Acting Chief of Staff and Deputy Commissioner for Strategic Initiatives, U.S. Food and Drug Administration (FDA) •Dr. Alicia Jackson, Director of the Advanced Research Projects Agency for Health (ARPA-H) •Congressman Kevin Mullin (CA-14), Representative of the Bay Area Longevity Biotech Ecosystem •Congressman Jim McGovern (MA-2), Ranking Member of the House Rules Committee and Champion for Nutrition and Healthy Aging Policy •Congressman Paul Tonko (NY-20), Co-chair of the Congressional Longevity Science Caucus
Tens of millions live with permanent disability after brain injuries such as stroke, disease, or aging. Current therapies help people cope but cannot restore lost brain function.
The BRAINS Exploratory Topic aims to advance regenerative neuroscience by engineering graftable precursor tissues and testing their integration into adult brains.
Now accepting proposals from bold, interdisciplinary teams.
ARPA-H is built to take on the toughest challenges in health by backing bold ideas, moving fast, and turning breakthrough science into real outcomes for patients. We focus on what others cannot and work to deliver results in years, not decades.
While you're at #bio2026, join us for two events at Booth 6157.
📍 Innovation to Impact: Investor & Commercialization Partner Showcase
The lymphatic system affects nearly every part of human health, but patients with lymphatic disease have been left without effective treatment options.
But now, ARPA-H Program Manager Kim Steele is turning one of medicine’s most neglected systems into a new frontier for diagnosis and treatment.
At yesterday’s Healthy Buildings Demonstration Session, ARPA-H was honored to receive a Leadership in Innovation Award from organizations championing cleaner, healthier indoor air.
Through BREATHE and PRO-MICROBE, ARPA-H is helping define a new future for indoor spaces, one where buildings can detect health threats earlier, respond faster, and better protect the people inside.
Science has proven it and Olympians, business leaders, and changemakers have all lived it - indoor air is critical to human health.
At ARPA-H's Healthy Buildings Demonstration Session, innovators from our BREATHE and PRO-MICROBE efforts demonstrated the breakthrough technologies that will raise indoor air quality to the level Americans deserve.
It’s time to bring the same public health ambition that transformed America’s water systems more than a century ago to the air we breathe indoors.
America’s mental health crisis demands more than awareness. It calls for action.
That’s why ARPA-H is investing $139 million in EVIDENT to accelerate the breakthroughs that will usher in the next era of mental health care. This week in Madison, EVIDENT’s 23 teams came together to launch the first two years of this urgent work.
This week also marked the culmination of a busy Mental Health Awareness Month for ARPA-H, in which we amplified the voices of the veterans, advocates, and innovators who are driving EVIDENT forward. Real progress is powered both by bold action and the people it is meant to serve.
If you’re building a U.S.-based life science company with a promising biomedical technology, America’s Seed Fund could help support your next stage of R&D.
Now is the time to review the new Notices of Funding Opportunity, confirm eligibility, and begin preparing application materials for the September 8, 2026 receipt date.
When @ARPA_H Program Manager Captain James Coburn visited Ginkgo for the start of Year 2 of the WHEAT program, Ginkgo CEO @jrkelly walked him through Catalyst — the software that runs our autonomous lab, Nebula. Every box in Catalyst is a step in a protocol mapped to a real piece of hardware on the lab floor. Drop in a node, connect it to the next, and the robots know that this plate needs to go to that device, get sealed, get spun, come out the other side.
It's how the science for the WHEAT program — turning wheat cell machinery into a domestic source for pharmaceutical ingredients — actually gets done.
Small businesses have always driven some of the most important breakthroughs in American medicine.
ARPA-H is looking for teams ready to take on hard problems and turn new ideas into real solutions for patients, from fertility and endometriosis to bioadhesives and robotics.
If you are building something that could change how we diagnose, treat, or prevent disease, we want to hear from you.
Review the draft solicitation and join our Proposers’ Day webinar on June 11.
ATTN innovators ready to change what hearing technology can do.
ARPA-H's Hearing Enhancement through Artificially Intelligent Neurotechnology (HEARING) program is an ambitious new effort to create the first brain driven, minimally invasive hearing system.
We are looking for teams that can bring together breakthroughs in neuroscience, otology, biomedical engineering, microelectronics, AI, machine learning, neuromodulation, clinical audiology, and regulatory science.
Hearing loss affects tens of millions of Americans, shaping how people communicate, work, connect, and move through daily life.
HEARING is designed to push past today’s limits and open a new frontier for people living with hearing loss.
Join us for Proposers’ Day on June 8, 2026.
This hybrid event will take place in Washington, DC, and online.
Gene therapy. Regenerative medicine. Fertility breakthroughs. The next leap in patient care is still to be built. ARPA-H is at #bio2026 in San Diego looking for ideas that can redefine what medicine can do and how quickly it can be delivered. We are focused on turning bold thinking into real solutions for patients. Request a meeting with our Program Managers and help drive what comes next. engage.arpa-h.gov/meetwithbio26
In rural America, the nearest specialist can be hundreds of miles away. That is one reason where you live can determine how long you live.
We can do better.
Through ARPA-H’s PARADIGM program, researchers at the @UMich are developing VIGIL, AI guidance designed for mobile care delivery platforms that bring hospital level care directly to rural communities.
For rural Americans, this means fewer long drives, earlier diagnoses, and faster access to high quality care.
ARPA-H is building a future where first-class healthcare is available to all Americans, and location no longer determines health outcomes.
Cleaner indoor air matters everywhere people gather.
ARPA-H’s BREATHE program is developing technologies to monitor indoor air quality, detect potential health threats early, and help make indoor spaces healthier and safer.
These technologies will be tested in daycares, schools, hospitals, and Defense Health Agency medical centers.
That means cleaner air could help protect children with asthma, students missing school because of respiratory illness, vulnerable hospital patients, and millions of military health beneficiaries.
BREATHE performers @virginia_tech , @poppy_health , @MayoClinic, and SafeTraces are helping bring this work into the places where people learn, heal, work, and gather.
Indoor air is one of the next frontiers in health, and during Allergy and Asthma Awareness Month and beyond, ARPA-H is working to make cleaner, safer air something people can count on every day.
For many veterans and Americans with serious mental health conditions, emerging treatments like psychedelics have been life changing.
Former Navy SEAL Marcus Capone experienced this after traveling abroad for ibogaine treatment when conventional options failed him. He and his wife, Amber, later co-founded Veterans Exploring Treatment Solutions to help other veterans access these therapies.
But stories alone are not enough to bring new treatments into the American healthcare system. We need rigorous ways to measure whether they work, who they work for, and how they can be delivered safely.
That is what ARPA-H’s EVIDENT program is building.
I was honored to be involved in this important discussion on the clinical and regulatory path for gerotherapeutics. @ARPA_H, @reaganudall and @xprize. Thankyou to our @HHSGov colleagues at @US_FDA for your contribution.
.@US_FDA Chief Scientist Dr. Steven Kozlowski provides opening remarks during our hybrid public meeting on Affecting the Aging Trajectory: Regulatory Constructs for Gerotheraeputic Drug, Biologic & Device Development.
Americans with mobility limitations deserve assistive devices that do more than help them get from one place to another.
What if mobility technology could help people navigate, interact with, and move through the world with greater safety, confidence, and independence?
ARPA-H’s Robotic Assistive Mobility and Manipulation Platform, or RAMMP, is working toward that future.
Earlier this month, ARPA-H Program Manager Mansoor Khan joined colleagues from Meta’s AI for Good initiative at the AI+ Expo in Washington, D.C. to share footage from a recent University of Pittsburgh demonstration and discuss how open source AI vision models are helping power RAMMP’s design.
RAMMP is pushing toward a future where assistive mobility technology is more intelligent, more adaptive, and built around the people who use it.
What if our schools, hospitals, and workplaces could autonomously ensure the air we're breathing is healthy?
Through our BREATHE and PRO-MICROBE programs, ARPA-H teams are developing technologies that can help make indoor air cleaner and healthier, while also detecting dangerous pathogens before they spread.
On Thursday, June 4, from 2–4 pm ET in Washington, DC, they will be presenting the technologies that will help shape the future of public health.
We invite stakeholders with an interest in healthy building design, environmental health, respiratory illness, and more, to connect with colleagues and explore what they are building.
Note that space is limited and location will be provided upon registration. Please RSVP below.
We don't have an objective, biologically based test that can tell us if a patient has depression or anxiety.
But these conditions are real, and they can profoundly affect a person’s health and daily life.
Veteran Chris Molaro, CEO and co-founder of ARPA-H performer NeuroFlow, built a digital platform to better integrate mental health into the healthcare system and give providers clearer, more objective information to guide care.
NeuroFlow’s platform helps identify behavioral health risks earlier and supports care teams in making smarter, more efficient decisions.
This work is part of ARPA-H’s EVIDENT program, which is developing and validating FDA-ready clinical endpoints to help bring rapid-acting therapies to veterans and all Americans who need them.
During Mental Health Awareness Month and beyond, ARPA-H is building a future where mental health care is measured more rigorously, delivered more precisely, and treated with the urgency it deserves.
ARPA-H exists to accelerate breakthroughs in health by backing bold ideas and moving them from concept to real-world impact faster than traditional models allow. We take on high-risk challenges and build the pathways to get solutions to patients.
While you're at #bio2026, join us for two events at Booth 6157.
📍 Innovation to Impact: Investor & Commercialization Partner Showcase
Aging is one of the biggest drivers of many leading causes of death in America, including heart disease, cancer, Alzheimer’s disease, stroke, diabetes, and chronic respiratory illness.
Yet much of medicine still treats age related diseases one at a time after they appear.
One drug for heart disease. Another for Alzheimer’s disease. Another for diabetes.
ARPA-H’s PROSPR program is working to change what is possible by helping create clinical endpoints for aging treatments.
On Wednesday, ARPA-H will present a new expert consensus to regulators at the FDA on the most practical way to run these trials today, helping move the field closer to clinical trials for healthspan extending interventions.
This is a key step toward turning promising science into treatments that help people stay healthier and more independent as they age.
Do not miss the conversation. Join virtually or in person.
ARPA-H is heading to #bio2026 in San Diego. If you are working on something that could change how patients live, whether in gene therapy, regenerative medicine, or fertility care, we want to hear about it. Request a meeting with our Program Managers and help define what comes next in medicine.
Did you miss our virtual discussion with Dr. Alicia Jackson, Director of ARPA-H? The recording is now available on our YouTube channel! 🎥 Catch the conversation and hear the insights anytime. Watch now: www.youtube.com/watch?v=KgHkVSx6C1o
This Memorial Day, HHS honors the brave service members who gave their lives in defense of our nation and remembers the families who carry their legacy forward.
Respiratory viruses, allergens, and pathogens like hantavirus can move through the places where people transit like airplanes and cruise ships or spend much of their lives, including schools, hospitals, workplaces, and homes.
ARPA-H’s BREATHE program is taking on one of the next great frontiers in public health by developing new ways to monitor indoor air, detect potential health threats earlier, and help make the spaces around us healthier and safer.
For Asthma and Allergy Awareness Month, we are excited to spotlight technology that could transform how we understand, monitor, and protect the air people breathe every day.
Some ideas are too important to stay on the sidelines. ARPA-H is at #bio2026 looking for the boldest thinking in health and biotechnology. We move with urgency to take ideas from concept to real world impact and deliver solutions patients are waiting for. Request a meeting and bring your best work forward. engage.arpa-h.gov/meetwithbio26
Thank you to Jesse MacLachlan of Reason for Hope and the Veteran Mental Health Leadership Coalition for advocating on behalf of veterans and all Americans.
Veterans and Americans struggling with mental health conditions should not have to leave the United States to access the care they need.
ARPA-H is supporting the advancement of evidence based, fast acting treatments like psychedelics so they can be safely integrated into the American healthcare system for patients who may benefit.
During Mental Health Awareness Month and beyond, ARPA-H will continue advancing evidence based mental health treatments capable of changing lives.
Personalized medicine has long promised treatments tailored to the individual patient. But making those treatments work reliably, affordably, and across diverse genetic backgrounds remains a major challenge.
That is what ARPA-H’s NEBULA program is working to solve.
A new milestone from @CellinoBio and Polyphron showed they can create patient derived stem cell lines from donors with diverse genetic backgrounds and engineer them into consistent tissue without starting from scratch for every patient.
Every step like this brings personalized regenerative medicine closer to reality for more Americans.
ARPA-H is committed to building a future where medicine works for everyone.
Scientific breakthroughs should not take decades to reach patients.
ARPA-H’s IGoR program is working to transform biomedical discovery by combining AI, advanced disease modeling, and a more connected research ecosystem to rapidly generate and test ideas at scale.
We are calling on teams across AI, computational biology, experimental science, and lab infrastructure to help build a faster and more interoperable future for biomedical research.
Interested in helping shape the future of science? Join us for the IGoR Proposers’ Day on June 9. RSVP by Noon ET on June 7.
Where you live should not determine the level of care you receive.
Today, too many Americans living in rural areas face long drives, provider shortages, delayed treatment, and limited access to critical healthcare services. For many patients, these hurdles can result in going without care altogether.
ARPA-H’s PARADIGM program is working to change that by bringing hospital level care directly to the communities that need it most.
Last week, @missionmobileNC debuted its ARPA-H funded healthcare delivery platform prototype, MARCUS. Program Manager Bon Ku, MD, and team saw firsthand how its modular design can deliver a wide range of healthcare services to patients, even in some of the most remote parts of America.
This is the future of rural healthcare. It is mobile, flexible, and closer to patients.
Modern medicine can transplant kidneys, hearts, lungs, and even skin. But we still cannot transplant a human eye and restore vision.
One of the greatest scientific barriers is the optic nerve. To make whole eye transplantation possible, researchers must be able to visualize and track nerve repair and regrowth as the eye reconnects to the brain.
That is why ARPA-H’s THEA program is seeking innovators developing novel, non-invasive approaches for optic nerve imaging.
If you are building breakthrough imaging technologies that could help make vision restoration possible for blind and visually impaired patients, ARPA-H wants to hear from you.
The full Sources Sought notice and submission instructions are available on sam.gov. Responses are due May 29, 2026.
Thank you to retired U.S. Army Captain Adam Marr for speaking with us during Mental Health Awareness Month and for continuing to advocate for better mental health care for veterans and all Americans in need.
Captain Marr has seen firsthand how novel therapies like psychedelics can change lives. Yet too many patients still cannot access these treatments, and the evidence needed to support broader adoption has lagged behind the need.
ARPA-H launched EVIDENT to help change that by developing better ways to measure mental and behavioral health and to accelerate promising new treatment approaches, including psychedelics.
Americans deserve a mental health system that moves faster and delivers treatments that actually work.
🔬Protecting health from contaminants like air pollution, arsenic, mine waste, and PFAS takes center stage in an upcoming NIEHS Superfund Research Program webinar series. Hear from scientists working across disciplines on June 1 and July 16.
Gene therapy. Regenerative medicine. Fertility breakthroughs. The next leap in patient care is still to be built. ARPA-H is at #bio2026 in San Diego looking for the ideas that can redefine what medicine can do. Request a meeting with our Program Managers and help drive what comes next.
I'm leading one of four Performer teams for the @ARPA_H BREATHE program. We're building a system that ensures clean air in buildings. We're demonstrating this in child care centers to improve health for kids and their families.
Would you knowingly drink a glass of water filled with dangerous pathogens, bacteria, and pollutants?
More than a century ago, water treatment and sewer systems transformed public health and saved countless lives. But we still have not done the same for the indoor air we breathe, where Americans spend roughly 90 percent of their time.
Whether it is a school, office, hospital, or home, we often have no idea if the air around us contains harmful invisible particles that could be affecting our health.
ARPA-H’s BREATHE program is working to change that by building technologies and systems that can monitor indoor air quality, detect potential health threats early, and help make indoor spaces healthier and safer.
On this Asthma and Allergy Awareness Month and beyond, ARPA-H is working to make cleaner indoor air a standard of modern public health.
Is it possible to manufacture medicines using the natural biological machinery found in a grain of wheat? Last year, @ARPA_H selected a team led by Ginkgo to find out.
To kick off Year 2 of this project, called WHEAT (Wheat-Based High-efficiency Enzyme and API Technology), we hosted ARPA-H to update them on our progress and show them Nebula, our autonomous lab. Ginkgo Scientist Jama Hadji-Yusuf and CEO @jrkelly walked ARPA-H Portfolio Lead Captain James Coburn through the software that powers Nebula, called Catalyst.
We don’t just have an autonomous lab. We’re running some of the coolest science in the world on top of it to solve some of the world’s biggest problems. We’re honored to work with ARPA-H and work towards using biology to support the public good.
The future of health will be shaped by the most capable minds in America, and ARPA-H is heading to #bio2026 in San Diego to meet them.
Visit us at Booth 6157, where ARPA-H Program Managers and leaders across the health innovation ecosystem will come together to surface bold ideas, explore collaboration, and identify the breakthroughs that can reach people faster.
Experience ARPA-H ALIVE, an interactive that brings the future of healthcare into focus and shows how emerging technologies can transform patient outcomes.
If you are working on something that could meaningfully advance patient care, request a meeting with our Program Managers and put your idea in front of the people who can help move it forward.
Every year, thousands of people experience cardiac arrest while hospitalized. The silent warning signs are there — but we haven’t had the tools to read them.
With funding from ARPA-H, researchers at the University of Pennsylvania built CAMEL, an AI system that reads the heart's electrical signals to flag danger 10–15 minutes before crisis strikes.
The hardest part of treating mental and behavioral health is knowing whether a treatment is actually helping the brain.
Today, many measurements still rely on patient questionnaires that are subjective and unable to capture what is happening in the brain moment by moment.
ARPA-H performer ATTUNE is working to change that by building the first wearable capable of both delivering low-intensity-focused-ultrasound neuromodulation therapy for chronic pain and depression and providing data-driven insights into how the brain is responding.
That means patients and providers could finally have a clearer understanding of which interventions actually work, helping move beyond the exhausting cycle of trial-and-error treatments.
ATTUNE is part of ARPA-H’s $139 million effort to transform mental and behavioral health through rigorous measurement and a new generation of fast-acting, personalized therapies.
Mental health care should be as measurable, precise, and data driven as the rest of medicine. Across Mental Health Awareness and beyond ARPA-H, is helping build that future.
America’s small businesses are a driving force behind biomedical innovation and play a critical role in keeping the United States at the forefront.
The technologies they are building today can become the market-ready solutions that change how we prevent, diagnose, and treat disease.
ARPA-H recently announced 15 contract awards to small businesses across eight states to advance work that can deliver life-changing solutions for patients.
These teams are taking on some of the toughest challenges in health, spanning wearables, artificial intelligence, diagnostics, and gene therapies.
We're thrilled to host Dr. Alicia Jackson, Director of @ARPA_H, on Thursday, May 21, from 11:00 a.m. to 12:00 p.m. ET on Zoom. This is a don't-miss event!
We've asked Dr. Jackson to share her vision and priorities for this important federal agency and provide a brief overview of the current project landscape. This event is open to the public. Register: us02web.zoom.us/webinar/register/WN_PQjU9w1-TomtiqgAStl_mg
Would you knowingly drink a glass of water filled with dangerous pathogens, bacteria, and pollutants?
More than a century ago, water treatment and sewer systems transformed public health and saved countless lives. But we still have not done the same for the indoor air we breathe, where Americans spend roughly 90 percent of their time.
Whether it is a school, office, hospital, or home, we often have no idea if the air around us contains harmful invisible particles that could be affecting our health.
ARPA-H’s BREATHE program is working to change that by building technologies and systems that can monitor indoor air quality, detect potential health threats early, and help make indoor spaces healthier and safer.
On this Asthma and Allergy Awareness Month and beyond, ARPA-H is working to make cleaner indoor air a standard of modern public health.
Thank you to Lieutenant General Martin Steele for speaking with us during Mental Health Awareness Month and for speaking openly about PTSD, stigma, and the urgent need for better treatment options for veterans and all Americans in need.
America’s mental health system is failing too many people. Treatments are still largely trial-and-error and often rely on outdated ways of measuring whether care is actually working.
@ARPA_H launched EVIDENT to help change that by developing more precise ways to measure, diagnose, and evaluate mental and behavioral health conditions and treatments.
A cancer diagnosis can mean months of treatment, difficult side effects, and overwhelming costs.
Radiotherapy is a core part of care, but it still falls short for too many patients.
ARPA-H’s 1-CURE program is working to develop a single, rapid, low-cost approach to treat all types of cancer, including metastatic and treatment-resistant disease.
A new advance against #ovariancancer: Researchers at Rice and @UTMDAnderson report promising first-in-human results for implantable “cytokine factories” that deliver immunotherapy at tumor location.
Following Public Service Recognition Week, I want to recognize the team at ARPA-H working to change the future of health in America.
Every day, they are taking on some of the hardest challenges in medicine with urgency, ambition, and a belief that patients should not have to wait decades for breakthroughs.
I am proud to work alongside people proving that government can still drive transformational innovation and deliver real results for the American people.
Every mother deserves real answers about whether the medications she needs during pregnancy are safe for her and her baby. For too long, that data has been limited or missing altogether.
ARPA-H’s BUMP project is working to change that by building “organ-on-a-chip” models of pregnancy, including the placenta, fetal heart, and soon, the fetal brain, to better understand how drugs interact with each one.
The future of maternal medicine is being built now.
HHS Mother’s Day Highlight: At the inaugural HHS National Conference on @womenshealth, @ARPA_HDirector Dr. Alicia Jackson shared how her sister’s heart attack became a driving force behind her leadership at @ARPA_H — and her mission to help others facing similar challenges.
Cancer care is often slow, expensive, and siloed. @SecKennedy took a different approach. Now, @ARPA_H’s 1-CURE is pushing breakthrough treatment — AI + smart radiotherapy — to reach MORE people, FASTER.
ARPA-H is heading to #bio2026 in San Diego. If you are working on something that could change how patients live, whether in gene therapy, regenerative medicine, or fertility care, we want to hear about it. Request a meeting with our Program Managers and help define what comes next in medicine.
Yet the air inside our buildings was never built to protect human health.
During National Asthma and Allergy Awareness Month, the gap is clear. Asthma affects 28 million Americans, and poor indoor air quality drives over $39B in healthcare costs each year.
A century ago, we transformed public health with clean water.
Now it is time to do the same for air.
ARPA-H’s BREATHE program is building intelligent systems that can sense what is in the air, assess risk in real time, and respond to protect the people inside.
Learn more about ARPA-H is transforming the air you breathe.
Headed to the AI+ Expo in Washington, D.C., this week?
Don’t miss these exciting presentations of the Robotic Assistive Mobility and Manipulation Platform (RAMMP) on Friday, May 8.
You’ll learn how this AI-powered prototype help people who use wheelchairs move through the world with greater confidence, safety, and control, while reducing reliance on caretakers.
Join Program Manager Mansoor Khan and colleagues from Meta’s AI for Good initiative for a 10:45am ET presentation on the Demo Stage. Then catch the 12:30pm panel, “Leveraging Meta's Open AI Models in Real-Time.”
We have more scientific knowledge, tools, and computing power than ever before, yet breakthroughs still take too long to reach patients.
That gap is not inevitable. It is a systems failure.
ARPA-H was created to close it by taking on the risks others cannot, building regulatory and manufacturing pathways from the start, and proving what works so the health ecosystem can move faster.
The future of medicine should reach patients in years, not decades.
Right now, it can take decades for breakthroughs to reach patients. A fragmented research system slows progress and leaves too many families without answers.
ARPA-H is working to change that.
We launched IGoR, a new program built to rethink how research happens. By connecting labs, enabling AI driven discovery, and making experiments faster and more reproducible, IGoR is designed to accelerate progress on even the most devastating complex and chronic diseases.
What if every child who came to the ER got the right care, as quickly as possible, without extra tests or transfers?
ARPA-H PM @LSMayMD joined Grand Rounds at Children’s National to tackle pediatric emergency readiness and unnecessary care. The vision is getting kids to where they need to be with even faster triage when they are critically ill.
This Public Service Recognition Week, I want thank the @HHSGov workforce of more than 78,000. I am proud to work alongside you as we take on the challenge to end the chronic disease epidemic and Make America Healthy Again.
ARPA-H does not settle for incremental progress. We exist to change the trajectory of human health, and that requires bold ideas and a model unlike traditional funding agencies.
The ARPA model, pioneered by @DARPA, is built around Program Managers with ambitious visions, accelerated timelines, and a focus on breakthrough technologies.
The next decade of medicine will be decided by who leads in biotechnology.
At the @CFR_org annual lecture on science and technology, .@ARPA_HDirector Alicia Jackson joined @SenToddYoung and ARPA-H performer Dr. Akhila Kosaraju of @PhareBio to discuss why the United States must act now to pull ahead of our competitors in drug development and biomedical innovation.
Winning means turning breakthrough science into real treatments faster and more reliably than anyone else.
Biotechnology shapes our health, our economy, and our national security. The country that leads in advancing these critical technologies will set the global standard in the decades to come
ARPA-H was built for this moment, to move faster, take bigger risks, and ensure the future of medicine is led by the United States.
Bringing together the Discovery Duos from the LIGHT and GLIDE programs was a powerful reminder that the best research is built with patients, not just for them.
The lymphatic system plays a critical role in maintaining balance and protecting the body from disease, yet it has long been overlooked in medicine.
By pairing early career investigators with patient or caregiver ambassadors, these teams are advancing lymphatics research in a way that is deeply informed by real experience and truly centered on patients.
What if one of the biggest breakthroughs in medicine has been hidden in a system we can barely see?
For decades, the lymphatic system has been overlooked, despite its role in diseases affecting millions of Americans. That is beginning to change.
We were honored to welcome Kathy Bates to ARPA-H to share her advocacy for those living with lymphedema.
At ARPA-H, we are working to unlock this hidden system, pushing the boundaries of what is possible and opening the door to a new era of medicine where disease can be understood, treated, and ultimately prevented at its source.
ARPA-H launched STOMP to confront one of the most urgent challenges in health, and America’s brightest minds rose to meet it.
At our Proposers Day, researchers, engineers, and innovators from across the country came together to tackle a fundamental question: what are microplastics doing in the human body, and how do we remove them?
It was our largest Proposers Day ever, a powerful signal that the urgency is real and the talent is ready.
ARPA-H will be awarding up to $144 million to the boldest, most promising ideas to drive this work forward.
Have a breakthrough approach to measure or eliminate microplastics from the body? Explore the STOMP program page to ask questions or connect with others building solutions. Solution summaries are due May 6.
If America wants to remain the world leader in biomedical research, we need transformative breakthroughs, at rapid speed.
Recently in Northern Virginia, ARPA-H brought together performers and government partners to discuss how we can work together to advance drug discovery and development using AI and digital tools.
Through our innovative programs, ARPA-H is investing in the technologies and infrastructure that will ensure America is the best place to develop therapeutics, so it continues to be the best place to receive care.
ARPA-H is redefining what freedom and possibility can look like for people who rely on mobility devices.
This week, ARPA-H performers at the University of Pittsburgh demonstrated the Robotic Assisted Mobility and Manipulation Platform, or RAMMP.
This AI powered system can navigate uneven terrain, open doors, and help people who use wheelchairs move through the world with greater confidence and safety, while reducing reliance on caretakers.
At its core, RAMMP is about giving people greater freedom, dignity, and independence in how they move through the world.
. @ARPA_HDirector Dr. Alicia Jackson, Chief Medical Officer @DrRafidFadul, and Mission Office Directors spent time with performers and partners across the city’s biotech community who are turning bold ideas into real breakthroughs.
From cutting edge research to new approaches in care, there is a shared drive to take on the hardest challenges in health and move faster than ever before.
The talent and energy in Dallas are undeniable, and it is accelerating the kind of breakthroughs that can transform medicine and change millions of lives.
The status quo in health innovation isn’t moving fast enough. Our SBIR/STTR draft solicitation is live! If you’re a small business building a breakthrough — not incremental change — this is your moment to work with us and push what’s possible. Learn more ⬇️
.@ARPA_H is awarding up to $139 million to revolutionize how we treat mental health through the bold new initiative, EVIDENT: Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health.
With EVIDENT, HHS is spurring new, effective therapies for behavioral health — including psychedelic research for populations with serious mental illness.
For millions of Americans, many treatments for mental illness never deliver relief. This is not acceptable.
@ARPA_H's EVIDENT initiative is awarding up to $139 million to accelerate the research, approval, and responsible access to breakthrough mental health treatments, including psychedelic therapies like ibogaine, to deliver real solutions for Americans with serious mental illness—especially our veterans.
America is in the middle of a mental health crisis.
Half of all Americans will experience a mental or behavioral health condition, with even higher rates among veterans.
Yet medical professionals still lack the objective tools needed to determine what treatments work and for whom. Too many patients are left cycling through care without clear answers.
ARPA-H’s EVIDENT program is working to change that by developing new ways to measure treatment effectiveness and evaluate emerging therapies, including psychedelics.
Thank you @POTUS@WhiteHouse and @SecKennedy for elevating this as a national priority through Saturday’s executive order to accelerate medical treatments for serious mental illness.
ARPA-H was built to take on challenges like this and deliver Americans transformative care at rapid speed.
What do microplastics mean for human health? And what can we do to remove them?
.@ARPA_HDirector Dr. Alicia Jackson joined @foxnewsradio to discuss ARPA-H's historic STOMP initiative, which aims to answer these questions and combat microplastics. Her interview begins at minute 15:30.
ARPA-H's BREATHE program is moving from lab to real life.
New partnerships with @MayoClinic and SafeTraces/ @StanfordHealth are expanding real world testing of air sensing and cleaning tech to affordably help Americans breathe healthier indoors. @JessicaLeeGreen
🧠The average American has a teaspoon full of microplastics in their brain — almost 1%.
That’s why we’re putting $140 million into the Systematic Targeting of MicroPlastics (STOMP) program at @ARPA_H to build a toolbox to measure, research, and remove microplastics from the human body.
Microplastics are in human blood, brain tissue, reproductive organs, and we still don’t fully understand what they’re doing to mitochondrial function, hormones, or long term disease risk.
We need better detection at scale, real research on how these particles interact with human biology, and practical ways to reduce exposure now, not years from now.
Start with what’s already in your control: - Clean your water. - Stop heating food in plastic. - Reduce synthetic fabrics against your skin. - Be intentional about what you’re putting in and around your body.
Current cancer therapies are extremely burdensome on a patient, requiring many visits to the doctor and stays in the hospital.
But soon, patients may be able to receive care and be monitored without ever having to leave home.
Through ARPA-H's THOR project, researchers at @RiceUniversity pad are developing a small implantable device to that will deliver the exact treatment cancer patients need, when they need it.
Ambitious projects like THOR are what will lead to transformative health breakthroughs and transformative, affordable care for Americans.
What if the future of medicine was not in your medicine cabinet, but right inside your body?
This is what ARPA-H's THOR project is working to achieve. ARPA-H funded researchers at @RiceUniversity are developing implantable smart-devices that will deliver treatments directly to patients.
With THOR, American patients can skip continuous visits to the doctor, long wait times, and missed dosages.
Affordable, effective healthcare is about more than just therapeutics, it’s about creating systems that allow for better access and treatment consistency.
Our homes are packed with microbes that shape how we breathe & fight illness 🦠That’s why ARPA-H’s PRO-MICROBE is backing Yale’s Healthy Building Microbiome Index—so families can expect healthier homes by design🏠 Learn more: www.yaleseas.com/magazine/2026/index.html?j=3261792&sfmc_…@YaleEngineering
Pregnancy is one of the most critical events in a woman’s life, yet we still lack clear answers on how drugs impact them. ARPA-H funded @DraperLab is building an organ-on-a-chip model to test medicines safely. Better data = safer treatments for women & families. @premierresearch
@landmarkbio has received up to $18.3M from @ARPA_H to build a scalable continuous manufacturing platform for extracellular vesicle therapies. Working with @MIT on the TRANSFORM EV project, Landmark Bio aims to tackle manufacturing bottlenecks, cut cost and timeline barriers, and improve access to next-generation EV-based therapeutics.
SynBioBeta 2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: www.syntheticbiologysummit.com
Effective and efficient clinical trials are critical to winning the biotech race and building better treatments for patients. @CedarTrials is showing what's possible — thank you so much for having us!
For decades, the answer to osteoarthritis was: deal with it.
Pain meds. Limited mobility. Lower expectations.
Through @ARPA_H, HHS is investing in bold, next-generation science to rebuild bone and cartilage — not just treat symptoms. Promising cures are on the horizon.
What are the most exciting things happening in biotech right now?
@zachweinberg: "Wait till people see these triple-G drugs. Muscle-sparing, no GI side effects — you get the weight loss but you keep your muscle. The pipeline is incredible."
@ToddYoungIN: "Sequence every flora, fauna — every living, non-human thing in our national parks and our public lands. The genetic traits of these animals and plants can be used to create new products that can improve human flourishing in the future. It's Lewis and Clark brought to the 21st century."
@DrAliciaJackson: "Being able to engineer neocortical tissue that we can use to repair brains with. Whether you've had a stroke or neurodegeneration — we're now at that point."
@friedberg: "Epigenetic reprogramming. There was a paper published out of China last week where they put these reprogramming factors on skin cells and reduced the age of the skin cells by 30 years after 12 days. It's pretty incredible."
“With funding from ARPA-H, three teams of researchers have regrown bone and cartilage, even entire knees, in animal studies. Human trials are not far off.” @NYTHealth@nytimes@ginakolata
Nearly 800,000 knee replacement procedures are performed each year in the U.S. alone, yet most implants last only 15–20 years.
Now, researchers at Columbia (@NadeenChahine, @thehunglab) are working to change that. With support from @ARPA_H, they’re developing a biological total knee implant made from stem cells and biodegradable materials—an innovation that could one day replace traditional metal and plastic devices.
Osteoarthritis is the 3rd most common disease in the U.S.
With funding from @ARPA_H, researchers at CU Boulder, @CUAnschutz and @ColoradoStateU developed therapies that help damaged joints repair themselves within weeks (animal studies).
Last week, ARPA-H launched a historic effort to understand, measure, and reduce microplastics in the human body. We are looking for some of the brightest minds in America to take on this challenge. Join us for Proposers’ Day on April 22 in Washington, DC. arpa-h.gov/explore-funding/programs/stomp
The NITRO program is one step closer to eradicating OA by enabling joints to heal themselves. By meeting aggressive research milestones, teams are on track to begin clinical trials next year. Read more about NITRO progress: arpa-h.gov/news-and-events/arpa-h-fast-tracks-regenerativ…@DrRossUhrich
The hardest problems in health will not be solved with incremental progress.
At ARPA-H, we work with some of the brightest minds in America to take on challenges others will not, moving quickly and delivering real results for patients. arpa-h.gov/careers
.@friedberg: "Ten years ago China published half as many scientific journal papers as the United States. I believe last year China published 50% more. What's going on from a research perspective in China? How have they created this advantage?"
"What we've seen is China very rapidly take the R&D lead in biotech, in biopharma. They've done this very concertedly by their sea turtles policy, which is attracting talent that has been trained in the US, other industrialized countries to come back to China, taking the IP, taking companies and biotechs, relocating them in China and funding it very, very strongly, billions of dollars into this industry."
"We used to think of China as our supplier. But the vast majority of Western pharma is doing licensing deals for Chinese molecules. About 50% of all licensing deals came out of China."
"Their number one goal is not to be a supplier to us, but to replace us. You can talk to any Chinese biotech pharma CEO and they will tell you 2028 is the year that they start launching therapeutics, advanced therapeutics, cell-and-gene therapies. They will launch them independently and globally."
We cannot regulate what we do not understand. Through @ARPA_H, we are launching STOMP—Systematic Targeting of Microplastics—to measure exposure, define risk, and remove microplastics from the human body.
ARPA-H-backed innovation is world-class. In one of the largest global competitions to predict how drugs behave, ARPA-H performer @inductive_bio took 1st place. Better tools like this mean safer drugs, faster development, and better outcomes for patients. www.inductive.bio/news/inductive-bio-wins-worlds-largest-…
Yesterday, @SecKennedy, @epaleezeldin, and @ARPA_HDirector Alicia Jackson announced a historic HHS-led initiative to assess the risks and exposures associated with microplastics.
As part of this effort, @ARPA_H is launching STOMP — Systematic Targeting Of MicroPlastics — a groundbreaking program focused on developing ways to remove microplastics from the human body.
Under the leadership of @POTUS, this administration is taking decisive action to confront the growing threat of microplastics and protect public health.
With the launch of STOMP — Systematic Targeting of MicroPlastics — HHS’ @ARPA_H is building a toolbox for measuring, researching, and removing microplastics from the human body.
.@SecKennedy: “We cannot regulate what we don’t understand. So, today, through @ARPA_H…we are launching STOMP: Systematic Targeting of Microplastics…to measure, to understand, and to remove microplastics from the human body."
UC San Diego Center for Healthcare Cybersecurity@UCSDHCyber
Cyberattacks have halted care and disrupted devices across U.S. clinics. In a new piece, @ARPA_H explains why it’s funding real-world cyber protections.
Proud our CHC team built CRASHCART, restoring critical systems fast when ransomware hits.
CIRCLE this date on your calendar! 📆 Are you ready to save lives by empowering ICU teams with AI-powered digital twin technology? Submit a solution summary for ARPA-H’s CIRCLE program by March 30 at 1pm ET. www.arpa-h.gov/explore-funding/programs/circle
Recent headlines remind us that hospital cyberattacks aren’t just plotlines on HBO’s #thepitt. Real lives are stake. Learn how we’re taking on the ARPA-Hard challenge to modernize hospital cybersecurity and protect patients across the country 🔏 arpa-h.gov/news-and-events/modern-cyber-defenses-resilien…
ARPA-H is operating at the leading edge of what is possible. We are working for and with America’s best and brightest in science and medicine to accelerate breakthrough science, derisk early-stage therapeutics, and pave a clearer path through regulation.
It was a big day at ARPA-H last week with U.S. Ambassador @KenHowery !
From tackling antimicrobial resistance to new AI tools that put patients in the driver’s seat, we covered the spectrum of how to change the course of human health.
Really good conversation with @ARPA_H Dr. Alicia Jackson and @zachweinberg at the @HillValleyForum on why the U.S. must lead in biotech and not let China get ahead.
What if cancer treatment didn’t take months? What if it took days? Our new 1-CURE program is aiming to develop a single, fast, low-cost radiotherapy treatment effective against all cancers—local, metastatic, even treatment-resistant tumors. Learn more ⬇️ solutions.arpa-h.gov/1-cure
Innovators packed the room at CIRCLE Proposers’ Day to reimagine the ICU 🏥 Have a bold idea to transform critical care with AI & digital twin tech? Learn more and submit a solution summary by Mar 30: www.arpa-h.gov/explore-funding/programs/circle
ICU teams fight to help patients survive critical illness. CIRCLE aims to give them 21st-century tools to fight smarter. With AI + digital twin tech, clinicians can personalize care in real time—when every second counts. 🎥 Watch Proposers’ Day highlights. arpa-h.gov/explore-funding/programs/1-cure
What if cancer treatment took days — not months? 1-CURE is pursuing a single, fast, low-cost radiotherapy effective across ALL cancers — even metastatic and treatment-resistant tumors.
To understand health impact of micro- & nanoplastics (MNPs), researchers need consistent, well-characterized materials. ARPA-H is gauging industry capability to manufacture standardized MNPs. Interested parties, reply to our RFI by 3/25. arpa-h.gov/news-and-events/rfi-sources-sought-standardize…
At @HHSGov Women’s Health Conference, @ARPA_HDirector Alicia Jackson shared how high-impact government R&D can close data gaps, accelerate diagnostics & treatments, and reach women everywhere. Bring your ARPA-Hard ideas: arpa-h.gov#womenshealth#healthinnovation
The hospital cyberattack in @HBO's #thepitt is fiction-the risk is real. Through DIGIHEALS, we are funding CRASHCART w/@UCSDHCyber to restore hospital networks - so clinicians can keep treating patients. See the team in action during a simulation at Valleywise Health in Phoenix.
Children with life-threatening rare diseases can’t wait for better data.
UNICORN is building a predictive model to determine which cell therapy designs deliver the safest, most durable cures — unlocking progress for ~600 rare pediatric diseases. arpa-h.gov/explore-funding/awards/3896
Babies recovering from congenital heart surgery deserve better monitoring. ARPA-H teams are building tiny, flexible heart sensors to spot trouble sooner — so more families can go home, together. In 6 months, study enrollment doubled.
ARPA-H’s ADAPT program met at @ASU to advance adaptive, data-driven cancer care. ADAPT teams are using predictive modeling + real-time tumor biology to match treatments as cancers evolve.
ARPA-H Program Manager Dr. Kimberley Steele asks: ▪️What if we could make the invisible visible? ▪️What if we could detect dysfunction before irreversible damage? ▪️What if targeting the lymphatic system could prevent — even cure — disease?
Patients deserve earlier detection. Better tools. Real solutions. It’s time to bring the lymphatic system out of the shadows — and into the future of medicine.
Creating more “Happy Birthday”s & “Happy Anniversary”s. By monitoring the immune system during critical care, CIRCLE will empower doctors to fine-tune treatments, halt disease progression & save lives.
There's a reason Boston is a global hub for health innovation. Thank you for having us for a second jam-packed day — the energy here is unmatched and we're just getting started.
For too long, the lymphatic system has been invisible in medicine. The day before #worldlymphedemaday (March 5), join us for “From Invisible to Invincible”— a community conversation about making lymphatic health visible, treatable & preventable.
We’re LIVE in Boston and surrounded by innovators who refuse to accept the status quo in health.
Boston is where biotech's brightest minds push boundaries and save lives. That's exactly why we're doubling down here ensuring every dollar drives game changing breakthroughs.
For decades, medicine managed chronic disease symptoms — while ignoring the system connecting them all. When it breaks down, the damage radiates everywhere — heart failure, diabetes, autoimmune disease, obesity. And there are zero FDA-approved treatments that actually repair it.
That ends now. Our GLIDE program will build the first therapeutic toolkit to repair, restore & regenerate damaged lymphatic vessels—launching a new field of lymphatic medicine. Meet the awardees ⬇️ (2/2) arpa-h.gov/news-and-events/arpa-h-glide-program-set-preve…
What if the ultimate health monitor was invisible? OCULAB teams are building sensors that live in your tear duct, read your body's chemistry in real time, and deliver treatment when you need it — not on a fixed schedule. arpa-h.gov/news-and-events/arpa-h-program-turns-your-eyes…
#throwbacktuesday The best ideas won’t stay in the lab. @ARPA_HDirector Dr. Alicia Jackson visited her alma mater @MIT to meet PhD innovators pushing science that didn’t exist a few years ago. Thanks, MIT!
Thanks to @ARPA_H for leading such an important dialogue about the critical importance of patient-centered care in the age of AI. It is always a privilege to join forces with so many brilliant minds in the childhood cancer community 🤝
Most diseases still lack an approved treatment—especially rare diseases. Our MATRIX project is identifying new uses for existing medications & unlocked up to $76M in additional funding to evaluate the most promising candidates in the lab & clinical trials. everycure.org/phase2/
We treat cancer. We treat diabetes. We treat heart disease. But aging — the #1 risk factor behind all of them — has no drug, no clear treatment, no regulatory pathway.
Deeply honored that @TIME published my thoughts on why aging should be medicine’s biggest priority. We’re at a turning point: high-risk, high impact science through @ARPA_H is finaly treating aging like the solvable problem it is. Grateful to be part of this moment.
Your proteins are making deadly typos. BIOGAMI is teaching them to spell correctly. When proteins in the body misfold, they can trigger diseases like ALS, Parkinson's & Alzheimer's –but what if we intervene before that happens? Proposers' Day highlights ⬇️ arpa-h.gov/explore-funding/programs/biogami
Meet the van with a plan 🚚 Brigham & Women’s Hospital (@BrighamWomens) rolled out their new mobile care vehicle prototype earlier this month at a kick-off event at Atrium Health in Charlotte, North Carolina! (1/2)
The project was funded by ARPA-H's PARADIGM program and is designed to close health gaps by delivering advanced care directly to rural communities. Check out the news story ⬇️ (2/2) www.wsoctv.com/news/local/atrium-healths-mobile-hospital-…
Today, we fight viruses AFTER people get sick. That’s too late. Our Broad-Spectrum Antiviral (BSA) project is advancing Synthetic Carbohydrate Receptors (SCRs) designed to target shared features across viruses — stopping infection before it becomes disease. (1/2)
Instead of chasing the next outbreak, we’re building a platform designed to work across endemic & pandemic threats—with potential beyond viruses. Prevent the exposed from becoming patients. It’s time for antivirals as adaptable as the threats we face. 2/2 arpa-h.gov/explore-funding/awardees
Today, ARPA-H is committing up to $144 million to tackle the functional decline that occurs during aging. For years I’ve wanted to see aging treated as something we can measure and change, not just endure. One of my biggest goals with PROSPR was to make rigorous human aging trials in non-diseased people. The 7 PROSPR teams will: - Find the earliest changes that predict long-term health - Test new and repurposed therapies in 1-3 year healthspan trials I’m thrilled to see this vision become real. Meet the teams bringing it to life: arpa-h.gov/news-and-events/research-teams-add-more-health…
Most of us don’t just want longer lives, but more years of good health. PROSPR awardees are spotting early signs that health is slipping, building systems for aging clinical trials & testing new drugs that could be the 1st gen drugs to extend healthy years arpa-h.gov/news-and-events/research-teams-add-more-health…
Join us firsthand at #vivevent Monday 9:30 AM PT. We'll talk about what actually matters: better outcomes for patients. @ARPA_H is cutting through the noise and focused on what works. See you there.
Today’s bold projects. Tomorrow’s breakthroughs. 🧬 ENGINE: AI to scale gene therapy manufacturing ⚡ HYPERDRIVE: Next-gen AI processors to accelerate biomedical discovery Explore these and other projects driving the future of health arpa-h.gov/explore-funding/awardees
... so your care never stops, even during an attack.
And through DIGIHEALS, we're adapting proven national security tech to detect threats before they hit and keep your medical records secure. arpa-h.gov/explore-funding/programs/digiheals
Your health care should never be held hostage. (2/2)
Thought-provoking read in @BostonGlobe on how anti-aging research could be 🔑 to a strong economy. It highlights ARPA-H as a risk-tolerant agency making promising investments in this space. Health aging is a major focus for us & we’re just getting started. www.bostonglobe.com/2026/02/06/opinion/antiaging-research…
Long overdue: ending the reality where zip codes determine survival rates for kids with cancer. This is what actual progress looks like — data, connection, action. Less talk, more of this.
Pediatric Care eXpansion (PCX) builds a digital backbone for pediatric care—connecting 200+ hospitals for near real-time data sharing—so a child’s zip code doesn’t decide their outcome. Thank you, Steph, for being part of our PCX roadshow and this vision to transform kids’ care.
It’s the first time anyone has ever given me a championship belt! Thank you and everyone at the PCX roadshow today. It is an honor to support such an important program and make an actionable impact on pediatric cancer!
Pediatric Care eXpansion (PCX) builds a digital backbone for pediatric care—connecting 200+ hospitals for near real-time data sharing—so a child’s zip code doesn’t decide their outcome. Thank you, Steph, for being part of our PCX roadshow and this vision to transform kids’ care.
200+ hospitals. One mission: ending pediatric brain cancer. Our Pediatric Care eXpansion (PCX) effort launched with $50M to ensure every child and their families have access to the best possible care, regardless of where they live. (1/2)
PCX connects children's hospitals so they can easily share important health information. No more incomplete records slowing down treatment. No more delayed diagnoses. Just faster, smarter, more connected care. (2/2) arpa-h.gov/news-and-events/arpa-h-announces-50m-expand-pe…
Critical illness moves fast. We need to track its every move. CIRCLE is making that possible — using AI + digital twin technology to control the body’s immune response in real time, so clinicians can personalize care when every second counts. arpa-h.gov/news-and-events/arpa-h-launches-program-revolu…
Cancer changes. Your treatment should too. Too many of our loved ones have been treated with a plan made on Day 1, even when their tumor evolves, resists, and outsmarts that plan by month three. (1/2)
World-class care, no matter where you live. Every town, every county, every zip code.
This week, ARPA-H collaborated with @HHS_Jim and @DrOzCMS to do something big: bring the future of health straight to rural communities. We’re not studying the problem – we're solving it. (1/2)
▫️Mobile hospitals bringing care directly to you ▫️Robot-assisted surgery in more places ▫️Protecting small-town health systems from hackers ▫️AI tools helping doctors treat heart disease (2/2)
🚨 BIOGAMI Proposers' Day Registration is closing soon – sign up by Feb. 18 at 5pm ET for in-person attendance, or by Feb. 19 at noon ET for virtual attendance.
PROSPR (Proactive Solutions for Prolonging Resilience) is tackling humanity's most ambitious challenge: stopping age-related diseases before they start, extending years of vitality.
Big healthcare breakthroughs rarely happen in silos. Our programs are built for multidisciplinary teams—bringing together builders across the biomedical ecosystem to turn ambitious ideas into real-world solutions.
Clinical need is constant. Supply chains aren’t. We can’t keep relying on slow and outdated paths to produce the active ingredients our medicines depend on.
WHEAT is building a simpler, scalable way to produce APIs — using American-grown wheat and wheat germ extract. (1/3)
Cold-chain logistics are a bottleneck, and patients can’t wait. BoSS is building room-temp stable biologics so cell and gene therapies can reach anyone, anywhere.
Unfolding Innovation: our new BIOGAMI program strives to eliminate diseases like ALS and Parkinson's by exposing the earliest stages of protein misfolding and clumping—stopping lasting damage before it starts. arpa-h.gov/news-and-events/rewriting-protein-grammar-stop…
Fresh from ADVOCATE Proposers' Day: the highlights you can't miss!
Program Manager Dr. Haider Warraich's vision is audacious: develop the first @US_FDA-authorized, agentic AI that delivers 24/7 specialty care for America's deadliest chronic disease. 🧵 (1/5)
“It was a privilege to present to the ADVOCATE program.” - Bilal N.
“ARPA-H convened Proposer's Day for ADVOCATE & if you're working in AI, digital health, or cardiovascular care, you should be paying attention.” - Randi S.
Proposers' Day was UNREAL & it's only the beginning.
Announcing our first CMO Rafid Fadul! Dr. Fadul brings a unique combination of clinical expertise & healthcare innovation leadership to his role, and he'll work to ensure that all our innovations have an impact for patients, providers, and payers. Welcome! arpa-h.gov/news-and-events/arpa-h-announces-first-chief-m…
Our mission is to solve healthcare problems by answering the bold and seemingly unanswerable—from advancing AI and tackling aging to building what doesn’t exist… yet.
If that sounds impossible, good. That’s how breakthroughs happen. (4/5)
ADVOCATE Proposers' Day was a huge success! @HHSGov Deputy Secretary @HHS_Jim joined @ARPA_HDirector Dr. Alicia Jackson and Program Manager Dr. Haider Warraich to discuss how AI can provide safe and effective cardiovascular care to every American. (1/2)
They covered the technical intricacies of creating an AI agent to serve around the clock as a new, digital member of the clinical care team, closing the gap in rural healthcare & saving lives—the latest example of how our investments are changing the course of human health! (2/2)
👋Do you have a great idea to produce, store, and transport cell and gene therapies without the need for refrigeration? 🏃 Hurry, registration for virtual attendance at BoSS Proposers' Day closes 1/25!
Attending @ARPA_H ADVOCATE Proposers’ Day in DC. This is a FANTASTIC program coming from the federal government: “What if an FDA-authorized clinical agentic Al could provide safe and effective cardiovascular care to every American?”
We got to see ARPA-H's investments in action. The teams spearheading the AVOID-OME, CT-NEURO, and VISION projects at UCSF, and those overseeing the HEART, BDF, PCX projects at Stanford, are making great progress! (2/2)
One year of MAHA. Under @HHSGov, we launched programs across: ➡️ Labor & delivery (MOCS) ➡️ Tissue engineering (FRONT) ➡️ Robotic surgery (AIR) ➡️ Agentic AI for heart failure (ADVOCATE) ➡️ Behavioral & mental health (EVIDENT) ➡️ Rare disease (THRIVE) ➡️ Biomanufacturing (GIVE)
And that’s not all. We announced $50M to expand pediatric cancer care across the country at JPM–not to mention millions in awards to ignite bold health innovations—from digital health security to cell therapy to lymphatics. (2/3)
We also brought together national leaders in clinical agentic AI, longevity, and bioelectronics to surface risky ideas for the hardest problems in health—where ARPA-H is uniquely positioned to act.
Announcing a historic investment in lymphatics research! The LIGHT performer teams will develop the 1st comprehensive diagnostic toolkit to allow healthcare providers to detect problems with the lymphatic system earlier, as part of a routine physical exam. arpa-h.gov/news-and-events/arpa-h-awards-1357m-illuminate…
“Lymphatic dysfunction quietly harms millions of Americans every year. Often, solutions are identified too late, if at all. This investment will help spur innovation to create efficient diagnostics that millions will benefit from. I look forward to the teams’ responses.” @HHS_Jim
✨We participated in panels across the city, including #jpmhc26, and hosted visits with Performers, meetings with potential Program Managers, and other engaging opportunities with the best and brightest in biotech.
Yesterday at #jpmhc26 we announced $50M to improve health outcomes for children with complex diseases across the country, beginning with pediatric brain cancer.
With support from leading companies in AI, data, and healthcare, the Pediatric Care eXpansion (PCX) aims to ... (1/3)
... shorten the care journey for patients from years to weeks by expanding data-sharing capabilities across more than 200 pediatric hospitals in the United States.
And earlier this week, we announced ADVOCATE, a program that asks, what if an FDA-authorized clinical agentic AI could provide safe and effective cardiovascular care to every American?
We're supporting @ARPA_H's PCX program—a $50M effort to share data between 200+ pediatric hospitals on complex cases, beginning with pediatric cancer. The goal is to help doctors learn from similar cases and shorten the care journey from years to weeks.
Today at #jpm2026, we announced $50 million to improve health outcomes for children with complex diseases across the country, beginning with pediatric brain cancer.
A first in organ transplantation! Announcing the performer teams for PRINT, our program to bioprint universally matched organs on demand—eliminating chronic shortages, long waitlists, and lifelong medication dependence. 🫀 arpa-h.gov/news-and-events/arpa-h-awards-teams-set-biopri…
Today at #jpm2026, we announced $50 million to improve health outcomes for children with complex diseases across the country, beginning with pediatric brain cancer.
Several leading companies in AI, data, and health care have pledged their commitment to support PCX through areas such as in-kind funding, computing credits for LLMs ... (2/3)
Yesterday, we hosted a Clinical Agentic AI event in SF and unveiled ADVOCATE, a program to revolutionize cardiovascular disease management with clinical agentic AI. Plus, we dove deep into the topic, with insights from government, clinicians, and funders. arpa-h.gov/news-and-events/arpa-h-revolutionize-cardiovas…
📢 Coming up at #jpm2026 at 11:15 am PT/2:15 pm ET: @ARPA_HDirector Alicia Jackson will discuss “Inventing What Comes Next: Make the Impossible Probable for Human Health.” #jpmweek
One of the most serious and preventable consequences of chronic disease is heart failure.
ARPA-H's frontier approach will accelerate AI adoption with a new model of care that can be applied across diseases, improving health and saving lives. @ARPA_H
Our new ADVOCATE program aims to revolutionize cardiovascular disease management with clinical agentic AI and become the first autonomous AI platform authorized for patient use by @US_FDA.
Hi from the west coast! 👋On Monday, we took the stage at #biotechshowcase and tomorrow, 1/14, we'll be at #jpm2026, where @ARPA_HDirector will discuss “Inventing What Comes Next: Make the Impossible Probable for Human Health” at 11:15 am PT. We made our first day in SF count!
In San Francisco for #jpmweek? Don't miss @ARPA_HDirector Alicia Jackson & @HHSGov Deputy Secretary @HHS_Jim discuss “Inventing What Comes Next: Make the Impossible Probable for Human Health” on 1/14 at 11:15 am PT.
Led by Program Manager Dr. Haider Warraich, this event will include roundtables on HHS Policy Initiatives to Advance Clinical Agentic AI, Clinicians in Tech on the Development and Integration of Clinical Agentic AI, & Health Tech Investors on Funding the Future of Healthcare. 2/2
Our new BoSS program aims to develop new methods to produce, store, and transport cell and gene-based biologic medicines at room temperature, with a goal of replacing high-cost refrigeration needs.
Headed to #jpm2026? Don’t miss @ARPA_HDirector Alicia Jackson & @HHSGov Deputy Secretary Jim O'Neill (@HHS_Jim) discussing “Inventing What Comes Next: Make the Impossible Probable for Human Health” on 1/14. Plus, we have exciting, exclusive news to share!
We’re hosting a #jpm2026 adjacent event focused on Defeating Disease with Clinical Agentic AI on 1/13 from 2-5pm PT. The event, led by Program Manager Dr. Haider Warraich, will include senior leaders from ARPA-H, @HHSGov, and more.
Our AIR (Autonomous Interventions and Robotics) program aims to revolutionize surgery by enabling robots to perform entire interventions without direct human input.
Program Manager Dr. Ileana Hancu hopes that chronic disability after stroke will "become a thing of the past." 1/2
Thank you to everyone who attended Proposers' Day in Bethesda and get those Solution Summaries in by January 20! (2/2) arpa-h.gov/explore-funding/programs/air
Headed to #jpm2026? We’re hosting an event in San Francisco on Tuesday, 1/13 from 2:00-5:00 pm PT focused on Defeating Disease with Clinical Agentic AI.
Led by Program Manager Dr. Haider Warraich, this event will bring together leaders from ARPA-H, federal agencies, healthcare, and tech to tackle what it takes to bring patient-facing agentic AI to scale — covering development, regulation, deployment, and reimbursement. (2/2)
HHS is advancing a national effort that uses current science to strengthen prevention, diagnosis, and long-term care for people affected by Lyme disease. Last week’s Lyme disease roundtable fulfills commitments made by the MAHA Strategy report to address invisible illnesses.
📣 Calling all experts in biology, chemistry, materials science, engineering, biomanufacturing, and preservation technology!
Learn about our new BoSS (BioStabilization Systems) program and register for Proposers' Day on January 29 in Washington, DC. arpa-h.gov/explore-funding/programs/boss
Our new BoSS (BioStabilization Systems) program seeks novel techniques to preserve cells at room-temperature, replacing high-cost ultra-cold storage needs, making biologics as shelf stable as aspirin.
Through our EVIDENT initiative, we aim to break through longstanding barriers in mental health measurement, diagnosis, and treatment — bringing faster, more precise solutions to all Americans. (1/2) arpa-h.gov/news-and-events/arpa-h-invest-leading-edge-app…
@ARPA_HDirector Alicia Jackson urged Proposers' Day attendees to “do your highest level of effort for every person who is suffering, for the veterans who have come back and are suffering.” Adding, “we can make a difference and we truly can change the course of human health." 2/2
#jpm2026, here we come! We're excited to explore partnerships, swap bold ideas, and accelerate health breakthroughs. Want to connect? 👉 engage.arpa-h.gov/meetwithjpm
We use OT to fund high-impact, high-risk research and development and attending a session offers significant advantages for researchers, companies, nonprofits, and government collaborators.
At MOCS (Making Obstetrics Care Smart) Proposers' Day, Program Manager Dr. Kate Arnold asked attendees, “what if the U.S. was the safest place in the world to have a baby?” Adding, “the field of labor and delivery deserves so much better – and that’s what you’re here for.” (1/2)
Our MOCS program will develop novel tools to transform labor and delivery from an era of guesswork into one informed by objective measures and more personalized care. Thank you to everyone who made MOCS Proposers' Day a success! arpa-h.gov/explore-funding/programs/mocs (2/2)
Let us know if you're interested in meeting with our Program Managers to discuss transformative ideas and potential collaborations. 👉 engage.arpa-h.gov/meetwithjpm26
Our AIR program intends to revolutionize surgery by enabling robots to perform parts of, or entire interventions, autonomously!
Register for hybrid Proposers’ Day on 12/16 in Bethesda, MD; an event for the proposer community to learn & make connections.🤝 arpa-h.gov/explore-funding/programs/air
Our new AIR program aims to benefit the millions of Americans who will suffer a stroke in their lifetime – and where timely clot removal matters for quality of life.
Dr. Jackson highlighted the growing #foodallergy crisis, ARPA-H’s ability to compress timelines for solutions, and its work with FAF and others to define the next priorities.
Let’s make obstetrics care smarter using innovative tools! Our new MOCS program (Making Obstetrics Care Smart) aims to raise the standards for safe and healthy births. 👶 arpa-h.gov/explore-funding/programs/mocs
We’re accelerating international collaborations that will enhance the impact of our initiatives on a global scale & recently hosted the K-Health MIRAE initiative in DC, welcoming a delegation of their program managers & leadership to explore opportunities with ARPA-H counterparts
BREATHE easy. 😮💨🫁 Announcing the 4 trailblazing teams for our program that aims to revolutionize public health by transforming a building’s ability to eliminate indoor air threats.
Our project with @UTAustin aims to develop technology for continuous, real-world monitoring of blood pressure, a key vital sign for assessing cardiovascular health.
In June, I had the privilege of speaking with the Muldoon family about the miraculous treatment that gave their son, baby KJ, a second chance at life.
Today, I am proud to launch two new @ARPA_H programs. THRIVE will speed the design of precision genetic medicines for many rare diseases. GIVE will place compact, automated manufacturing units in hospitals to produce those medicines safely, close to the children who need them.
Together, these programs represent a nine-figure HHS investment—helping us go from saving one baby like KJ to saving thousands, because every family deserves access to lifesaving treatment.
Our new programs aim to revolutionize genetic medicine development and manufacturing! 1⃣ THRIVE aims to develop affordable precision genetic medicines for all Americans 2⃣ GIVE aims to ignite innovative biomanufacturing for cell and gene therapies More: arpa-h.gov/news-and-events
In addition to speaking about “Development Pathways for Rare Disease Therapies” at today's @ASGCTherapy#ps25, we launched a program with Program Manager Dr. Mimi Lee!
Dr. Mimi Lee presents @ARPA_H’s multi-ecosystem collaboration for precision medicine. Exciting examples of cross-sector innovation in #raredisease#cgt development! #asgctadvocacy#ps25
Our new programs aim to revolutionize genetic medicine development and manufacturing! 1⃣ THRIVE aims to develop affordable precision genetic medicines for all Americans 2⃣ GIVE aims to ignite innovative biomanufacturing for cell and gene therapies More: arpa-h.gov/news-and-events
NEW: With cutting-edge production technologies, our GIVE program seeks to establish the U.S. as a frontrunner in advanced manufacturing methods for high-quality genetic medicines. Learn how ➡️ arpa-h.gov/news-and-events/arpa-h-launches-program-ignite…
How can federal IT leaders scale solutions across diverse ecosystems and overcome legacy tech roadblocks?
At the GovCIO Media & Research Health IT Summit, Andrew Carney, Program Manager at ARPA-H will tackle this question head-on. Discover how bold, scalable innovation is driving the future of health tech, even in the face of historic IT challenges.
Our project with @IcahnMountSinai aims to: 🗺️ Create a comprehensive computational map of pathogen-host interactions 💊 Uncover the best drug targets for an entire family of pathogens, instead of each individual pathogen as it’s done today (1/2)
💻 Test approved therapies and discover new ones via computer models
Learn more about the Closing the Doors to All Pathogens Through Integrated Digital Experiments (DOORs) project (2/2) 👇 arpa-h.gov/explore-funding/awardees
Yesterday, Acting @ARPA_HDirector Jason Roos participated in @HHSGov roundtable “Invisible Illness: Leading the Way on Long COVID” alongside @SecKennedy and other government health agency leaders.
On #longcovid he says, "This is a problem we all have to tackle together." (1/2)
On having a high risk, high reward model, Roos says, "Speed is our middle name. Our job is to accelerate better health outcomes & we're committed to doing this quickly.”
Roos discusses Long COVID progress barriers & where ARPA-H's R&D investments might be placed to address them.
We are thrilled to be a part of the new tech partnership with the UK, working with our partners overseas to advance bold AI solutions for health — especially for precision medicine and rare and chronic diseases. 🇺🇸🇬🇧 www.whitehouse.gov/presidential-actions/2025/09/memorandu…
🚨 President Donald J. Trump and U.K. Prime Minister @Keir_Starmer JUST SIGNED A HISTORIC Technology Prosperity Deal to usher in the next Golden Age of Innovation for a future of freedom and prosperity! 🇺🇸🇬🇧
Our project with @Stanford aims to establish data partnerships to expand the PRIME registry (the largest primary care data registry in the U.S.) by 50%, building an enriched dataset to help clarify the social determinants of health and causal drivers of disease. (1/2)
Learn more about AFC Health: The American Family Cohort: Enhancing and Validating Primary Care Data for Improving Urban and Rural Health (2/2) 👇 arpa-h.gov/explore-funding/awardees
Through the MATRIX project, ARPA-H is harnessing AI to accelerate drug repurposing and supporting @EveryCure’s mission to unlock the full potential of existing medicines to treat more diseases. (1/2)
15 years ago I said goodbye to my friends and family because I thought I wouldn’t survive… Today our TED talk goes live that could help us save patients.
In this inspiring #tedtalk, Every Cure co-founder @DavidFajgenbaum highlights how this work is reshaping what’s possible in the search for new treatments.
Our project with @UofNorthDakota aims to develop edge computing technology to create advanced machine learning models that will predict and improve diabetes foot ulcer risk prediction and wound healing prediction for senior citizens with diabetes. arpa-h.gov/explore-funding/awardees
Our project with @CUBoulder aims to develop cutting-edge technologies aimed at preserving the health and function of biological tissues under urgent stress or injury conditions. Learn more 👇 arpa-h.gov/explore-funding/awardees
Our health care industry is driven by data. And like every data system it has its vulnerabilities.
Escalating cyberattacks are disrupting patient care, stealing personal data, and destabilizing medical infrastructure. We must stare down this threat.
Between 2018 and 2024, more than 650 ransomware incidents targeted our health care providers, compromising nearly 89 million patient records and causing almost $22 billion in downtime losses.
Unlike other industries, hospitals must maintain 24/7 uptime and they don’t get to reboot.
To address health care cyber vulnerability, we need bold innovation at the intersection of AI, cybersecurity, and health. We need an assertive, proof-of-work approach.
That’s why, over the past two years, @HHSGov and @DeptofDefense , through @ARPA_H and @DARPA , have led the AI Cyber Challenge to protect our Nation’s health care from cyber threat. We brought together innovators to build next-generation open-source digital health security solutions.
President Trump’s executive order, “Sustaining Select Efforts to Strengthen the Nation’s Cybersecurity” calls for greater action to defend our digital infrastructure.
This summer, the teams identified 52 synthetic 0days in Java and C and patched 47. They identified 18 real 0days and patched 11.
I was honored to speak at #defcon33 to help present the awards.
Program Manager Dr. Jean Hebert talks about our new FRONT program which asks, what if we could restore function to the millions of Americans with permanent brain damage to the neocortex?
Our AI Cyber Challenge asked teams to deliver world-changing cyber defense systems to protect critical infrastructure at speed & scale – and they delivered. Congratulations to Team Atlanta for earning the top prize! Trail of Bits won second place, & Theori won third.
It’s almost time! Join us LIVE at 11 a.m. PT at the @defcon Track 2 Stage or tune into the DEF CON livestream as DARPA and ARPA-H celebrate the winners of the AI Cyber Challenge (AIxCC)! www.youtube.com/live/RLrDxbhpc5M
We’ll announce the results and winners of the DARPA AI Cyber Challenge (AIxCC) on Friday at DEF CON 33. For more on the challenge, the teams, and the AIxCC Experience at the event, visit: aicyberchallenge.com.
#aixcc#defcon33 schedule Fri, 8/8: ▫️11 am PT: #aixcc Program Manager Andrew Carney provides competition debrief & announces the winners 🏆 ▫️2:40 pm PT: “From Data Security to Discovery: How ARPA-H is Using AI to Transform Health Care in America” (panel) aicyberchallenge.com
A return to independence. Current treatments for severe brain damage only restore partial function. FRONT aims to heal and repair brain tissue and enable individuals with brain damage to recover lost functions.
Healing from within to restore brain health. From Alzheimer’s disease to traumatic brain injury, FRONT aims to revolutionize how we treat brain damage and restore cognitive function. 🧠
Step into the lab at @JohnsHopkins and see our SARRTS (Supervised Autonomous Robotic Renal Tumor Surgery) project in action by observing a robot perform a demonstration of tumor removal surgery on a "phantom kidney."
Had the pleasure of attending the “Make Health Tech Great Again” event hosted with @CMSGov at the @WhiteHouse. This movement aims to help build the next-generation of the patient-centered digital health ecosystem.
Congratulations to Dr. Susan Monarez on her milestone appointment to @CDCDirector!
Dr. Monarez previously served as our Deputy Director and will now lead @CDCgov's efforts to prevent disease and respond to domestic and global health threats.
Congratulations to Dr. Susan Monarez, PhD, on her Senate confirmation as the 21st Director of the Centers for Disease Control and Prevention. She brings decades of distinguished experience in health innovation, disaster preparedness, global health, and biosecurity to @CDCgov. Dr. Monarez will lead @CDCgov’s efforts to prevent disease and respond to domestic and global health threats, advancing @SecKennedy’s mission to Make America Healthy Again.
The "Science is National Security" panel at the #sciencesummit highlighted AI's role in maintaining U.S. competitiveness. From DOE's (@ENERGY) strategic labs to @ARPA_H's health security innovations, collaboration is key. 🌟
A return to independence. Current treatments for severe brain damage only restore partial function. FRONT aims to heal and repair brain tissue and enable individuals with brain damage to recover lost functions.
In the latest Vitals, we launched a bold program focused on restoring brain function called FRONT (Functional Repair of Neocortical Tissue). Plus, we’re headed back to #defcon to join @DARPA in announcing the winners of the AI Cyber Challenge (#aixcc). engage.arpa-h.gov/arpa-h-launches-bold-program-focused-on…
Exciting news! This month’s issue of @SciRobotics about Autonomy and AI in Medical Robots includes research from one of our Small Business Innovation Research (SBIR) projects, “Advanced Imaging Aided Autonomous Robotic Cholecystectomy.” 👏
The July issue of Science #robotics is out! This month's special issue highlights autonomy and #ai in medical robots.
The cover features a surgical robot that can complete steps of a gall bladder removal procedure autonomously when guided by a framework. scim.ag/4lm50wu
Healing from within to restore brain health. From Alzheimer’s disease to traumatic brain injury, FRONT aims to revolutionize how we treat brain damage and restore cognitive function. 🧠
NEW: No technology currently exists to repair damaged brain tissue and fully restore lost function. FRONT aims to enable millions with what is considered permanent brain damage to regain lost functions, including motor control, vision, and speech. arpa-h.gov/news-and-events/arpa-h-launches-program-restor…
Program Manager Dr. Jean Hebert talks about our new FRONT program which asks, what if we could restore function to the millions of Americans with permanent brain damage to the neocortex?
NEW: No technology currently exists to repair damaged brain tissue and fully restore lost function. FRONT aims to enable millions with what is considered permanent brain damage to regain lost functions, including motor control, vision, and speech. arpa-h.gov/news-and-events/arpa-h-launches-program-restor…
It was great connecting with global thought leaders at the intersection of science, business, and policy in Boston. Thank you to the incredible speakers who joined us across panels. #biotech#bioconvention
We’re headed to #hopkinsonthehill today, and excited to see science in action from two project awardees! 🔹SARRTS: Supervised Autonomous Robotic Renal Tumor Surgery 🔹PAIL: PhotoAcoustic Imaging technology for diagnostic Lung assessment arpa-h.gov/explore-funding/awardees
HHS proudly welcomes @DrOzCMS as the new @CMSGov Administrator. Together, we’ll protect the vulnerable, promote healthy lifestyles, modernize care, and give Americans more power over their health. Better care. Better outcomes. Let’s Make America Healthy Again.
.@SecKennedy visited the Native Health in Phoenix, AZ to learn how local leaders are addressing the chronic disease epidemic affecting tribal communities. By prioritizing healthy, unprocessed, and culturally relevant foods, they are creating meaningful, community-based solutions.
Thank you to Native Health for being a shining example of how we can Make America Healthy Again.
This week on our MAHA Tour of the Southwest, @SecKennedy had the pleasure of visiting Hózhó Academy Charter School — a shining example of how to integrate healthy eating and physical activity into daily student life. Their Arete Wellness Program, developed from JFK's Presidential Fitness Program, reflects a powerful commitment to student health and well-being.
We are streamlining HHS to make our agency more efficient and more effective. We will eliminate an entire alphabet soup of departments, while preserving their core functions by merging them into a new organization called the Administration for a Healthy America or AHA. This overhaul will improve the health of the entire nation — to Make America Healthy Again.
X posts that erroneously attribute Biden-era tweets supporting masks, lockdowns, vaccine mandates, etc. to my @CDCgov Director nominee, Susan Monarez, have understandably provoked agita within the MAHA movement. I handpicked Susan for this job because she is a longtime champion of MAHA values, and a caring, compassionate and brilliant microbiologist and a tech wizard who will reorient CDC toward public health and gold-standard science. I’m so grateful to President Trump for making this appointment.
We make pivotal investments in breakthrough technologies & platforms, capabilities, resources & solutions with the potential to transform important areas of health that cannot readily be accomplished through traditional research or commercial activity. arpa-h.gov/about
Our model is a continuous cycle of planning, implementing, and evaluating, health-related challenges that are ripe for solving. arpa-h.gov/about/arpa-h-model
.@SecKennedy had an important discussion today with doctors regarding President Trump’s historic No Surprises Act. HHS is committed to protecting patients from unexpected medical bills.
Curious about how Other Transactions can enhance your work? Our OT Community is here to guide you with all the info you need. From training resources to real-life tips, we’ve got you covered. arpa-h.gov/engage-and-connect/other-transaction-community
What types of impacts do we pursue? It includes expanding what’s technically possible, reaching everyone quickly, keeping people from becoming patients, just to name a few. arpa-h.gov/about/our-research
I so enjoyed my meeting with tribal leaders and elders from my advisory committee. Past administrations have treated @IHSgov as a red-headed stepchild. This administration will make Indian Country a priority.
No stone will be left unturned in our effort to end chronic disease. The health of our children is a higher calling for all of us. Watch my message to America and join me in this effort to Make America Healthy Again.
Our unique business model gives us the flexibility and efficiency to optimize resources, scale quickly, and drive innovation across the health care ecosystem. arpa-h.gov/about/arpa-h-model
We measure our success through technologies that graduate from the agency, translate to real-world products and services, and accelerate better health outcomes for all Americans. arpa-h.gov/about
How are we tackling aging? Our new PROSPR program aims to unlock the early signals in your body that predict age-related health issues before they happen. arpa-h.gov/research-and-funding/programs/prospr
At #jpm25, Cure CEO @SeemaJJIC moderated a panel titled "Through Non-Dilutive Capital - Women's Health As A Case Study." @ARPA_HDirector discussed seeing ARPA-H as a supportive investor, showcasing their Sprint for #womenshealth initiatives as an example of outcome-based contracts tailored to companies' efforts, unlike traditional grants. Plus, @SabrinaDareCEO shared how her clinical-stage biopharmaceutical company is committed to advancing innovative products for women's health.
What is the biggest barrier to getting novel #medtech to market?
Attend a virtual info session on 1/17 to learn more about our new network survey in support of @ARPA_H's effort to accelerate medical device and diagnostic reimbursement!
We’re at #biotechshowcase in San Francisco! Catch Deputy Director Susan Monarez’s workshop: “Financing Future Innovations: Raising the Money Needed to Get to the Next Inflection Point” today, 1/15 at 10:00-11:00 am PT. informaconnect.com/biotech-showcase/agenda/3/
Attending #jpm2025? Don’t miss “The ARPA-H Advantage: Transforming Health Through Non-Dilutive Capital - Women's Health As A Case Study” today at 2:15 pm PT with @SeemaJJIC and @SabrinaDareCEO! #jpm25
Explore the opportunities in Women’s Health at RESI JPM! Hear from top investors as they discuss funding trends, unmet needs, and strategies in this critical space—spanning therapeutics, diagnostics, digital health, and beyond.
If you are at #jpm2025 Healthcare Week, check out the PROSPR presentation today with our Program Manager Andrew Brack at the @R42 Longevity Showcase! lu.ma/0gan7pm5
What if we had therapies to extend healthspan and prevent age-related diseases? This week, we talk with @BrackLab, program manager of PROSPR, an ARPA-H initiative building infrastructure for interventions that maintain health during aging.
If successful, our RAPID program will expand access to rare disease expertise and help patients and health care providers reach an accurate diagnosis in a fraction of the time it takes today.
☎️ Calling RNA researchers to fill out this survey to inform ARPA-H investments in RNA manufacturing platforms! We aim to streamline access to affordable, high-quality, and scalable RNA manufacturing.
The Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program aims to transform the diagnosis of rare and ultra-rare diseases by developing highly accurate AI-based detection models.
Research into early age-related changes will help us create better strategies to extend our health span and improve quality of life for all. arpa-h.gov/research-and-funding/programs/prospr
.@ARPA_H wants to streamline access to affordable, high-quality, and scalable RNA manufacturing. RNA researchers are invited to complete a survey to share insights on RNA market demand and distribution.
Don't miss your chance to participate in the Emerging Health Innovators (EHI) virtual Proposers' Day on January 8! Registration closes at noon ET on Monday, January 6, 2025. solutions.arpa-h.gov/Events/EHI/
Register for the Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Proposers’ Day today! Registration closes at noon ET on Tuesday, Jan. 21, 2025. solutions.arpa-h.gov/Events/RAPID/
What if we could diagnose rare diseases in a fraction of the time it takes today? RAPID aims to transform the diagnostic journey, enabling rare disease patients and their families to get the answers and care they need—faster. arpa-h.gov/research-and-funding/programs/rapid
What if we had therapies to extend healthspan and prevent the onset of age related diseases? I’m excited to announce my first @ARPA_H program, PROSPR. The goal is to develop validated surrogate biomarkers, new clinical endpoints and therapies to collectively extend healthspan by 20 years for all Americans.
What if we could predict age-induced health issues before they happen? Our new PROSPR program aims to identify biochemical and physiological markers, paving the way for faster, more targeted aging research. arpa-h.gov/news-and-events/arpa-h-launches-new-program-ai…
What if we could predict age-induced health issues before they happen? Our new PROSPR program aims to identify biochemical and physiological markers, paving the way for faster, more targeted aging research. arpa-h.gov/news-and-events/arpa-h-launches-new-program-ai…
Our project with TigaTx aims to create an innovative therapy platform to fight cancer and infectious diseases by harnessing the power of engineered IgA to activate immune cells. arpa-h.gov/research-and-funding/mission-office-iso/awardees
.@ARPA_H wants to streamline access to affordable, high-quality, and scalable RNA manufacturing. RNA researchers are invited to complete a survey to share insights on RNA market demand and distribution.
⏳ Many of our funding opportunities are time-limited—don’t miss your chance to be part of transformative health breakthroughs! Check back regularly for new programs, research initiatives, and more. arpa-h.gov/engage-and-transition/open-funding-opportunities
Let’s explore how we can work together to make groundbreaking health care solutions a reality at #jpm2025 in San Francisco! 🌟 We are excited to connect with innovators and shape the future of health care. Express interest today: share.hsforms.com/2m9SG61RQSf-XinunwWa5sQebkh9
Thank you to leading health and science researchers and innovators in Australia for the opportunity to engage in discussions, demonstrations, and exchanges on areas of health and innovation that are significant to our mission. arpa-h.gov/engage-and-transition
Dr. Amy Jenkins, our Health Science Futures Mission Office Director, said it best, “@ARPA_H is boldly investing in this novel research area because we envision a future where cancers are treated more quickly and easily.”
NEW: Our ImagiNg Data EXchange (INDEX) program aims to help doctors diagnose patients faster through a robust and trustworthy AI-trained platform that can review medical images quickly and effectively.
So nice to see @ARPA_H's REO project, which aims to create two unique oral therapeutics to treat metabolic diseases including diabetes and obesity, acknowledged in the @Nature portfolio. www.nature.com/articles/s41586-024-08202-5
We appreciated the opportunity for our International Partnerships Lead, Amy Lin, to join an interagency panel discussion on how international collaboration can further transformative health breakthroughs. arpa-h.gov/engage-and-transition/international
Ken Shepard @bioee_columbia@columbiaBME is leading a multidisciplinary team of researchers in a new @ARPA_H grant, up to $41M, to tackle treatment of diabetes and obesity. The team, including our partners at @ColumbiaMed , will develop bioelectronic devices that enable people to administer treatments of biologic drugs without the need for injections. Congratulations to the Shepard lab and team!
Our team is heading to the #jpm2025! Don’t miss the chance to meet us in San Francisco and discuss how to accelerate projects and navigate the path from concept to commercialization.
Are you heading to #jpm2025? We are! 🙌Join us in San Francisco to discuss how our streamlined business practices can help transform your innovative ideas into impactful health solutions. #jpm2025
👏👏👏 Congrats! Our CT-NEURO project aims to develop cell-based therapies to deliver treatments to the brain, nervous system and other tissues, improving patient outcomes for hard-to-treat diseases, including glioblastoma, a deadly cancer! arpa-h.gov/news-and-events/arpa-h-funds-project-develop-t…
Bravo to Wendell Lim, PhD, and team for making the cover of @ScienceMagazine! The team armed immune cells with “molecular GPS” to find and treat brain cancer, MS and type I diabetes. Clinical trials could begin as soon as 2025. @CDI_UCSF@ARPA_H@theNCI tiny.ucsf.edu/BeJ9N2
An engineered T cell (center) is designed to deliver therapies to the brain. This T cell displays orange synthetic receptors on its surface, which recognize components of extracellular matrix fibers that are only found in the brain. Within the cell, downstream signaling pathways are programmed to initiate transcription and release a therapeutic payload—shown as light blue protein secretions.
ARC Centre of Excellence in Synthetic Biology@ARC_CoESB
Our final keynote for #coesb24#day2 was delivered by Dr Megan Frisk, Director for International Affairs at the Advanced Research Projects Agency for Health @ARPAHealth. 🌟
ARPA-H is driving transformative biomedical and health breakthroughs—from the molecular to the societal—to deliver health solutions for all. 🧬✨
Her talk, ARPA-H and Synthetic Biology: Expanding Technical Possibilities for the Future of Health, showcased how synthetic biology can revolutionise healthcare.
Thank you, Dr Frisk, for an inspiring presentation! 🙌
Attending #rsna24? Don’t miss “Deep Tech Innovation in Medical Imaging: The Roles of EIC and ARPA-H" with Program Manager Dr. Ileana Hancu today at 4:30 PM CST! @RSNA
Hear from @ARPA_H Program Manager Calvin Roberts, M.D. to learn about the new OCULAB program which aims to develop a tear-based biomarker measurement platform.
THEA intends to revolutionize the reconnection of nerves to the brain and develop breakthroughs in transplantation, preservation, and neuroscience. @ARPA_H's investment has the potential to repair vision loss for millions of Americans!
Exciting moment captured! 📸 The first full gathering of ARPA-H Digital Health Security Initiative (DIGIHEALS) program performers was a success! 🤝✨ Each group shared their scope & achievements, showcasing incredible talent & innovation! arpa-h.gov/research-and-funding/programs/digiheals
At @ARPA_H, we enable dynamic visionaries to tackle a specific problem, potentially in mental health, and turn seemingly impossible ideas into solutions for the real world. (2/2) arpa-h.gov/research-and-funding/arpa-h-model
Lived experience leads the way in GLIDE! By creating a mechanism for performers and lymphatic disease patients to collaborate, we are empowering patients to contribute to the scientific process. arpa-h.gov/research-and-funding/programs/glide/patient-en…
The goal of GLIDE’s Discovery Duo program is to make lymphatic disease research more accessible, affordable, and inclusive — centered around what matters most: the patient experience. arpa-h.gov/research-and-funding/programs/glide/patient-en…
"Since 2018, there's been a 300% increase in money in venture capital being invested in women's health. But, even though it's increased 300%, the bad news is - that is still 2% of all the venture capital in the U.S. that goes into health care."
During the Future of Health Summit today, our "Connecting the Dots for Women's Health: Research Innovation, Access, and Care" panelists discussed solutions for translating advances in research into improved real-world outcomes for women.
How can we use data and technology to improve outcomes for women? Dr. Jenica Patterson joins a panel at @MilkenInstitute today at 2:30 PM EST to discuss!
📅Register for OCULAB Hybrid Proposers' Day on 12/12 in Tampa, FL and help us revolutionize tear-based diagnostics for real-time health insights! arpa-h.gov/research-and-funding/programs/oculab
How can we use data and technology to improve outcomes for women? Dr. Jenica Patterson joins a panel at @MilkenInstitute today at 2:30 PM EST to discuss!
Headed to @ASTMH's #tropmed24? Don't miss “The Power of Partnership: The Role of the US Government in Advancing Global Health” on Nov. 14 at 12:15 pm ET! www.astmh.org/annual-meeting
Sign up to Vitals Newsletter and keep your finger on the pulse of ARPA-H, from program announcements and funding opportunities to milestones and stories of those who work here. engage.arpa-h.gov/arpa-h-vitals-newsletter-sign-up
It’s #socialmediakindness Day. You are enough. You inspire us. Thank you for existing. We support everyone who is sharing positivity, encouragement, and thoughtfulness. Take the time to be kind to one another. 🤗
Get an exclusive inside look at the ARPA-H business model to help set your organization up for success! Secure your spot today. solutions.arpa-h.gov/Events/DBWA/
🚨 The deadline to register for Doing Business With @ARPA_H Industry Day is tomorrow! This virtual event will provide attendees with the tips, tricks, and tools to successfully locate and apply for R&D funding opportunities. Register now! go.investorcatalysthub.org/l/1047663/2024-09-16/jy48
What are we interested in? Expanding what’s technically possible. Reaching everyone quickly. Keeping people from becoming patients. Building integrated health systems… just to name a few focus areas! arpa-h.gov/research-and-funding
Get an exclusive inside look at the ARPA-H business model to help set your organization up for success! Secure your spot today. solutions.arpa-h.gov/Events/DBWA/
Headed to the @agingbiomarkers 2024 Biomarkers of Aging Conference? Check out Dr. Andrew Brack's session cutting-edge research on reliable biomarkers of aging for longevity interventions! www.agingconsortium.org/conference-2024
🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟
We’re excited to welcome Prof. Andrew Brack (@BrackLab) of @ARPA_H to Day 2 of the Conference!
Dr. Brack joined ARPA-H in April 2024 from the University of California San Francisco’s Department of Orthopaedic Surgery. For 16 years, his lab studied the cellular and molecular mechanisms that regulate skeletal muscle repair during aging. He was the co-founder of Arrive Bio, a longevity company that uses machine learning to identify drugs to treat age-related diseases. Throughout his career Brack has led multidisciplinary teams with the goal of restoring healthy function during aging.
Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Dr. Brack and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions.
Thank you to @ARPA_HDirector Dr. Renee Wegrzyn for commemorating the Investor Catalyst Hub’s first anniversary and highlighting how our diverse, ever-growing network of members is working collectively to reshape health outcomes across the U.S. and the world. @ARPA_H#arpaneth
RD Handford attended an inspiring listening session w/ @ARPA_H, the chancellors of the UMass campuses, and state representatives to learn about innovative approaches being taken to advance research in MA, followed by a tour of @UMassChan’s New Education & Research building.
We’re kicking off a day of community-building and networking here at @portalinno with @medtechcenter! Excited to gather in person with spokes, IC Hub and @ARPA_H colleagues to foster conversations around growing a collaborative ecosystem in southeastern health tech innovation.
Congratulations to @ARPA_H's UPGRADE program for being named #cyberscoop50 INNOVATION OF THE YEAR! This critical program is one way we're investing in ways to build stronger, healthier, and more resilient health care systems. (1/2) cyberscoop.com/cyberscoop-50-winners-2024/
The R&D communities’ response to our call for women's health solutions was nothing short of incredible -- highlighting the urgent need to reshape the landscape of women’s care. arpa-h.gov/engage-and-transition/sprint
We’re tackling the biggest, hardest problems in human health, led by visionaries who can take the measure of that challenge and wrangle it into real-world solutions. arpa-h.gov/careers/what-is-a-program-manager
Arunan Skandarajah, Innovation Fellow at @ARPA_H presents "ARPA-H: Program Manager 101" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by @LifespanIO.
🚨 LAST DAY to submit your responses to the ARPA-H Emerging Health Innovators (EHI) Initiative! Don’t miss your chance to open new doors to community-based innovations and inclusive solutions to improve health outcomes for all Americans. www.customerexperiencehub.org/network-survey-for-emerging…
Are you an international entity or nonprofit? This event is perfect for you! Learn how to navigate the funding process and secure support for your projects. Registration closes at 12pm ET on November 8, 2024. solutions.arpa-h.gov/Events/DBWA/
The goal of @ARPA_H's EHI Initiative is to foster innovation that improves health for all. Whether you’re an early-career investigator or a community-based innovator, there’s a place for you to create change! (1/2) arpa-h.gov/news-and-events/arpa-h-launches-initiative-ear…
The goal of GLIDE’s Discovery Duo program is to make lymphatic disease research more accessible, affordable, and inclusive—centered around what matters most: the patient experience. arpa-h.gov/research-and-funding/programs/glide/patient-en…
We’re excited to share we’ve been selected by @ARPA_H as an awardee of the #sprintforwomenshealth! Thank you ARPA-H for sharing our vision of developing an at-home treatment to control the virus that causes cervical cancer. shorturl.at/ycxgK Image Credit: @invcatalysthub
Final Call! Complete the EHI Survey today! The survey expires 10/25 at 11:59 p.m. ET. @ARPA_H's EHI Initiative has the goal of ensuring that the agency identifies + engages early career investigators & community innovators. Complete survey here: www.customerexperiencehub.org/emerging-health-innovators-….
@ARPA_H's #sprintforwomenshealth initiative is about more than health — it’s about inclusivity, collaboration, and bringing unheard voices into the fold.
Dr. Susan Monarez is at #hlth 2024 to talk about the importance of building faster, less expensive trials with decentralized processes. Our ACTR effort is one example of how we are tackling this challenge. arpa-h.gov/news-and-events/arpa-h-advances-initiative-imp…
We want to understand next-generation Agentic Artificial Intelligence (AI) systems and their potential applications to accelerate better health outcomes for everyone!
While we are pushing the boundaries of innovation across the health ecosystem, we are proud to have uniquely transformational #cancer-related programs and projects committed to tackling the disease at every angle—from diagnostics to prevention. arpa-h.gov/news-and-events/arpa-h-two-years-how-agency-la…
#breastcancerawarenessmonth is a good reminder that early detection truly saves lives. Regular screenings, like mammograms and self-exams, can catch breast cancer early when treatment is most effective. Schedule a screening for yourself and remind those around you to do the same.
Our Division of International Affairs Director, Dr. Megan Frisk, shared how we aim to engage global stakeholders in identifying collaborative research, funding, and transition prospects that align with our agency's mission at @wef#gfc24! arpa-h.gov/about
Check out Acting Director of Data Innovation Dr. Alastair Thomson’s talk about data fabrics for public health TODAY at the @theNCI 10th Cancer Research Data Commons Fall Symposium!
Save these dates for the Cancer Research Data Commons 2024 Fall Symposium on October 16-17. The event will cover new work, including our AI Data Readiness Initiative and collaboration with @ARPA_H to develop a Biomedical Data Fabric Toolbox. go.nih.gov/KrHDYjm#datascience
Both researchers and lymphatic disease patient ambassadors learn from each other in the GLIDE Discovery Duo program, creating a bidirectional exchange of insights that enhances lymphatic disease research! arpa-h.gov/research-and-funding/programs/glide/patient-en…
We are excited to engage global stakeholders in identifying collaborative research, funding, and transition prospects that align with our agency's mission. @wef#gfc24arpa-h.gov/about
Our exciting event is designed for anyone interested in receiving support from our agency—whether you're a large company, small business, nonprofit, or in academia! 🎯 solutions.arpa-h.gov/Events/DBWA/
During Doing Business With ARPA-H Industry Day participants can attend sessions, ask questions, and engage in informal conversations with staff! Register today! arpa-h.gov/news-and-events/events
Next week at the @wef#gfc24 we are looking forward to connecting with international partners to identify opportunities that support our mission and elevate the impact of our programs and projects worldwide! vimeo.com/799970082
Our seventh annual Greater LA Life Science CEO Summit will kick off with a fireside chat between Dr. Deborah Birx, CEO of Armata Pharmaceuticals, and Dr. Joe Shonkwiler, COO of @ARPA_H. Learn more and register: www.biocom.org/conferences/ceo-summit/ceo-summit-los-ange…
Nobel Laureate David Baker on the phone with fellow awardees Demis Hassabis and John Jumper. The trio discussed how their teams have inspired one another and what the future may hold.
It's #nationalprimarycareweek. Our HEROES program wants to empower primary care teams & others to improve health with a payment model that incentivizes positive outcomes - reducing the health care burden on patients, providers, & the economy. arpa-h.gov/research-and-funding/programs/heroes
This week I presented at the ARPA-H GLIDE Proposers Day. What a fantastic opportunity to share about the work we’re doing at Rho Bio, a project focused on lymphatic medicines. Eager to connect with researchers and contribute to advancements in the lymphatics field. @ARPA_H#glide
✨ From detecting health risks to solving care availability issues, our mission office-specific funding opportunities are designed to shape the future of health care. What are your innovative ideas? arpa-h.gov/research-and-funding/mission-office-iso
Planning to attend @biocom? Don’t miss the Fireside Chat on Oct. 9 at 1 PM. Our Chief Operating Officer, Joe Shonkwiler, will be talking with @realDrBirx.
Our seventh annual Greater LA Life Science CEO Summit will kick off with a fireside chat between Dr. Deborah Birx, CEO of Armata Pharmaceuticals, and Dr. Joe Shonkwiler, COO of @ARPA_H. Learn more and register: www.biocom.org/conferences/ceo-summit/ceo-summit-los-ange…
Save these dates for the Cancer Research Data Commons 2024 Fall Symposium on October 16-17. The event will cover new work, including our AI Data Readiness Initiative and collaboration with @ARPA_H to develop a Biomedical Data Fabric Toolbox. go.nih.gov/KrHDYjm#datascience
Our Proactive Health funding opportunity focuses on creating capabilities to detect and characterize disease risk and promote treatments and behaviors to anticipate threats whether viral, bacterial, chemical, physical, or psychological. arpa-h.gov/research-and-funding/mission-office-iso
We are proud to have launched uniquely transformational cancer-related activities committed to tackling the disease at every angle—from diagnostics to treatments to prevention. arpa-h.gov/news-and-events/arpa-h-two-years-how-agency-la…
Catch PATIO Deputy Director Melissa Antman at the @bioNorthTX iC3 Summit! Learn how streamlined business practices can accelerate innovation to the marketplace! Register to attend: biontx.org
Dr. Susan Monarez is at the 2024 @HealthRAorg members meeting with @raekaaiyar, @UABHeersink’s Dr. Anath Shalev, and @NIH_NINDS’ Dr. Amir Tamiz to talk about ways we can catalyze the therapeutics development ecosystem.
Our Resilient Systems funding opportunity aims to invest in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.
Thank you @USAmbDenmark for the warm welcome to our team! We are excited to engage international partners to explore research, funding, and transition opportunities that align with our mission, amplifying the global impact of our initiatives.
Mission Office Director, Dr. Amy Jenkins, and Program Manager Dr. Kim Steele were at @nih_nhlbi 's NCLD to explore innovative models to address the diverse needs of the lymphatic community, ensuring a more inclusive approach to care. www.nhlbi.nih.gov/events/2024/national-commission-lymphat…
As a pediatrician I know how important a healthy foundation from food truly is. Today I'm excited to announce our new #foodismedicine Initiative to integrate nutrition into healthcare & fight diet-related diseases. For helpful resources visit our new site: health.gov/foodismedicine
What if a simple home test could save millions by catching cancer early?
POSEIDON will develop 1st-in-class, synthetic Multi-Cancer-Early Detection tests for sensitive/specific stage 1 detection of 30 solid tumors using only breath and/or urine samples. arpa-h.gov/news-and-events/arpa-h-launches-program-develo…
AI is completely changing health care, so what if we could make it more accurate? Our PRECISE-AI program will help AI-enabled medical tools maintain peak performance. 💪
NEW: Our TARGET project aims to use artificial intelligence to find and deliver at least 15 new candidates to help replenish global tools against emerging antibiotic-resistant pathogens. arpa-h.gov/news-and-events/arpa-h-project-accelerate-disc…
“Antibiotic resistance is a real and urgent threat affecting millions of people. This project will use AI to speed this needed innovation and help ensure we have the medicines we need to keep people alive.”
ICYMI: @ARPA_HDirector joined a panel of thought leaders @MilkenInstitute's #miglobal Asia Summit for a discussion on efforts being made to increase focus & funding for women's health.
Thank you to @MGBInnovation#wmif2024 for the great chats on our agency's ability to tackle health care challenges that the rest of the funding ecosystem can’t take on and our unique business model! arpa-h.gov/about
Exciting project from @Stanford! With the goal to develop a fully automated, scalable approach to optimize medical chatbots, they aim bring reliable, patient-facing AI tools closer to everyday use. 👏👏👏
Innovation in small-batch gene therapy manufacturing is critical for advancing tailored solutions for individual patients. Share your expertise with us through the DECIDE ET by October 22! sam.gov/opp/44a7073a51894651a2e38487ba82f49c/view
Our CAIDF project aims to create scalable solutions to unlock previously underutilized nursing, PT, occupational therapy and speech and language pathology data with routinely collected medical data and integrate it with AI technology. @thisisUICarpa-h.gov/research-and-funding/mission-office-iso/awardees
By making routine procedures safer and more affordable with efforts like @VUEngineering's ALISS, we aim to bring advanced health care closer to everyone.
Researchers from @VanderbiltU and @VUMChealth plan to develop a fully autonomous surgical robot within the next three years. The project is supported by an award of up to $12 million from @ARPA_H.
When Eliz Amar Lewis saw her grandma battle breast cancer, it inspired her to create a sophisticated therapeutic. Now, she’s developing an RNA-based cancer immunotherapy platform funded by @ARPA_H . Learn more about Eliz & her work in this month’s #howyss. wyss.harvard.edu/news/humans-of-the-wyss-eliz-amar-lewis-…
We’re in Boston for the Women’s Health Innovation Summit! Join us on September 24 as we discuss the “White House Initiative on Women’s Health Research: (Almost) a Year in Review.” #sprintforwomenshealth
🚫 Avoid common application mistakes! Learn best practices for applying to our funding and boost your chances of success. 🌟 See you on Wednesday, November 13. solutions.arpa-h.gov/Events/DBWA/
News you should CARE about! Announcing the awardees for the CARE ET. These talented teams will work on creating tools and technology to improve how we assess medical chatbots, combining the speed of computers with the precision of human experts. arpa-h.gov/research-and-funding/mission-office-iso/awardees
We are excited to partner with @VanderbiltU on the Autonomy at a Less Invasive Scale in Surgery (ALISS) project to develop modular tools and smart systems for autonomous robotic surgery, making procedures safer and less invasive. arpa-h.gov/research-and-funding/mission-office-iso/awardees
Exciting times ahead in Texas! PATIO Deputy Director Melissa Antman will discuss how streamlined business practices are helping transform research into real-world solutions. See you at the @bioNorthTX iC3 Summit! www.biontx.org
Our Chief Information Officer, Nikolaos Ipiotis, is at the @GovCIOMedia Health IT Summit talking about standardizing data, reducing health disparities, and the power of AI. govciomedia.com/health-it-summit
We are looking for innovation teams with expertise in microbiome science, predictive analytics, and access to facilities with health outcome data to respond to our PRO-MICROBE Exploration Topic.
Congratulations to the next round of Small Business Innovation Research (SBIR) awardees! 🎉
Their innovative R&D contributions will help transform the landscape of health care and we can't wait to see what's next! arpa-h.gov/engage-and-transition/sbir
This is a major effort to develop a single data system for the latest in #biomedical research, and performer teams will contribute to making medical research findings easier to use to improve health outcomes for Americans! (2/2)
Speaking of women's health, we're addressing critical unmet challenges in women’s health, championing transformative innovations, and tackling health conditions that uniquely or disproportionately affect women with our #sprintforwomenshealth! (2/2) arpa-h.gov/engage-and-transition/sprint
I sat down with the next generation of innovators & scientists at @SJSU.
Through the new @ARPA_H Emerging Health Innovators Initiative, we're taking steps to ensure that more Latinos & other under-represented communities will be involved in research & innovation going forward.
Through activities like the EHI Network survey, we are working with @HHSgov to 📍 Enlist fresh perspectives 📍 Better ensure our products and capabilities meaningfully impact all communities 📍 Cultivate the next generation of leaders in the life sciences arpa-h.gov/news-and-events/arpa-h-launches-funding-opport…
Program Manager Dr. Kim Steele has a message for the lymphatic disease community: “We have the potential to transform lymphatic medicine from a once invisible and undervalued discipline to one recognized as essential for our health.” (1/2)
ICYMI: Check out the @LymphaticNet symposium featuring Program Manager Dr. Kim Steele talking about her Groundbreaking Lymphatic Interventions and Drug Explorations (GLIDE) program 👇 youtu.be/Vsp6oAn5sXg
📢 Exciting event alert! Learn how to successfully apply for our funding and make your proposals stand out. Don't miss out on this valuable opportunity on November 13! solutions.arpa-h.gov/Events/DBWA/
The @BioHealthCR Forum is celebrating its 10th anniversary 🎉and we have plans to introduce you to our Project Accelerator Transition Innovation Office (a new national partner for emerging #biohealth companies). Join us on September 18! 👇 reg.eventmobi.com/bhcr2024/pages/forumagenda
What are Health Science Futures? Here, they are initiatives that accelerate advances across research areas and remove limitations that block progress towards solutions for broad ranges of disease and conditions! arpa-h.gov/research-and-funding/mission-office-iso
What if a simple home test could save millions by catching cancer early?
POSEIDON will develop 1st-in-class, synthetic Multi-Cancer-Early Detection tests for sensitive/specific stage 1 detection of 30 solid tumors using only breath and/or urine samples. arpa-h.gov/news-and-events/arpa-h-launches-program-develo…
The future of health care relies on partnerships! Later this month, international delegates will gather for the #tourdehealth '24 "Partnering for Sustainable Health Innovation" conference in Copenhagen and we are honored to serve as U.S. delegates. (1/2) tourdehealth.dk/delegates-from-the-us/
Our mission office-specific ISOs allow us to fund health-related technology research and development outside of the traditional grant or contract structure. Check out all 4: arpa-h.gov/research-and-funding/mission-office-iso
🚀 We are incredibly excited to announce @CellinoBio has been awarded $25M from @ARPA_H! This funding supports our research efforts to make personalized regenerative therapies accessible to #patients, bringing “Your Cells, Your Cure™” to fruition. bwnews.pr/4gfrjlb
In this episode of “The Other 80” recorded at #aspenideashealth, @ARPA_HDirector spoke with host @claudiawilliams about how our unique tools – from flexible hiring to novel contracting – are speeding up groundbreaking health solutions!
Ready to make an impact in osteoarthritis treatment? Meet us in D.C. on Sept 17. Network with leaders and drive the conversation forward. Register by tomorrow, Sept 10! solutions.arpa-h.gov/Events/NITRO/
What if patient charts were streamlined, automated & significantly easier to prepare? DAGCAP is a modular, interoperable, comprehensive end-to-end workflow aimed at decreasing chart curation effort by 90% while maintaining human-level accuracy. @VUMChealtharpa-h.gov/research-and-funding/mission-office-iso/awardees
ICYMI: We launched PRECISE-AI, which aims to make AI-enabled tools more reliable & @ARPA_HDirector shared w/ @MilkenInstitute how we make pivotal investments in high-risk, high-reward ideas that cannot be achieved through traditional research or investment engage.arpa-h.gov/vitals-09-05-2024
NEW: From virtual assistants to enhanced medical imaging and diagnostic tools, AI is transforming the way doctors provide care. So, what if we could make it more accurate?
🎉 The @ARPA_H IC Hub has surpassed 500 spoke members! In just 10 months, our network has welcomed some of the greatest leaders in health care innovation in 48 states across the private, public, and nonprofit sectors. Apply today to join the network! go.investorcatalysthub.org/l/1047663/2024-04-10/7jry
Dr. Kimberley Steele, Program Manager in the Health Science Futures Office at @ARPA_H, will present about the new funding opportunity on August 28 at 12:00 pm ET.
Our Administration launched the first-ever White House Initiative on Women’s Health Research to fundamentally change how we approach and fund women’s health research in the U.S.
Together, we will drive innovation in women’s health and close research gaps.
We’re holding a 3rd NITRO Osteoarthritis Meeting on September 17 in Washington, DC.
Don't miss the opportunity to connect and collaborate with OA leaders, including industry, academic, federal, and regulatory. Register by September 10. solutions.arpa-h.gov/Events/NITRO
Attention folks in oncology, biopharma, biotech, medtech & health tech!
We launched POSEIDON, a program to develop at-home Multi-Cancer-Early Detection tests, and now we're inviting you to a day of learning in Baltimore next month (Sept. 4)! Register now: solutions.arpa-h.gov/Events/POSEIDON/
Attention folks in oncology, biopharma, biotech, medtech & health tech!
We launched POSEIDON, a program to develop at-home Multi-Cancer-Early Detection tests, and you're invited to a day of in-person learning on Sept. 4 in Baltimore. Register now! (1/3) solutions.arpa-h.gov/Events/POSEIDON
WATCH: This week, @POTUS and @FLOTUS announced up to $150 million in ARPA-H awards to eight trailblazing teams selected for our PSI program to create new technology that ensures perfect cancer tumor removal.
Here's a clip of President Biden making remarks at the event. ⬇️
NEW: Today in New Orleans, @POTUS and @FLOTUS will announce up to $150 million in ARPA-H awards to develop technologies that will allow surgeons to provide more successful tumor-removal surgeries for people facing cancer. (1/4) www.whitehouse.gov/briefing-room/statements-releases/2024…
Attention folks in oncology, biopharma, biotech, medtech & health tech!
We launched POSEIDON, a program to develop at-home Multi-Cancer-Early Detection tests, and now we're inviting you to a day of learning in Baltimore next month (Sept. 4)! Register now: solutions.arpa-h.gov/Events/POSEIDON/
💬 News you should CARE about: We launched the Chatbot Accuracy and Reliability Evaluation (CARE) Exploration Topic (ET) to produce tools and technology to better evaluate medical chatbots for patient-facing applications. arpa-h.gov/news-and-events/arpa-h-launches-exploration-to…
Let there be LIGHT! Our new program envisions a future where health care providers will have a scalable, accessible, accurate, and clinically useful comprehensive toolkit to assess lymphatic health. arpa-h.gov/news-and-events/arpa-h-launches-program-cataly…
NEW: We’re partnering w/ @DARPA on the Artificial Intelligence Cyber Challenge (AIxCC) to safeguard the nation’s health care infrastructure from cyberattacks.
The Transplantation of Human Eye Allografts (THEA) program aims to transplant whole human eyes to restore vision for the blind and visually impaired. Don’t overlook the importance of THEA! (Too cornea?) arpa-h.gov/news-and-events/arpa-h-program-aims-restore-si…
📢We are holding a second bi-annual NITRO Osteoarthritis Model Symposium for the potential proposer community and performers on February 22, 2024. Registration is required! nitro-oa-model-symposium.powerappsportals.us
🤝 Join us at 11 AM PST to shape the framework of our Ethical, Legal, and Social Implications (ELSI) of research! Let's discuss and innovate together! 🚀 #hlth2023
How do we create a health innovation network that reflects the people we serve?
Our ARPANET-H is one way we are opening up to a diverse talent pool and tapping into brilliance from all communities across the nation. arpa-h.gov/news/arpanet-h/
📢 NEW: We are thrilled to launch our ARPA-H Digital Health Security effort, a groundbreaking project to safeguard the U.S. healthcare system's electronic infrastructure. 🛡️ Join us in protecting vital healthcare data from cyber threats! arpa-h.gov/news/digiheals/
❗BREAKING NEWS: We're launching our first cancer-focused program, PSI, aimed at developing technologies to help surgeries for cancer and other conditions fix the problem perfectly👌✅, the first time! arpa-h.gov/engage/programs/psi/
🚀BREAKING NEWS: We're thrilled to launch our first program, NITRO, aimed at revolutionizing the care for millions suffering from osteoarthritis through groundbreaking approaches to tissue regeneration. Join us on this journey of discovery and innovation! arpa-h.gov/engage/programs/nitro/
💥NEW RFI 💥 We are looking for novel insights, ideas, incentives, approaches, and models to help accelerate innovation while prioritizing patient safety for better health outcomes. Submit today! arpa-h.gov/news/fda/